INTEGRATED RESEARCH LIMITED - Annual Report 2012

Providing Business Insight

==> picture [137 x 43] intentionally omitted <==

Integrated Research Annual Report

==> picture [134 x 127] intentionally omitted <==

==> picture [135 x 127] intentionally omitted <==

2012 ABN 76 003 588 449

Access your Annual Report 2012 online. Visit ir.com/annualreports2012

This report is printed on Impress paper which is FSC certified.

Fibre is sourced from well managed forest plantations and controlled sources.

2 | Integrated Research and its controlled entities | Annual Report 2012

==> picture [240 x 842] intentionally omitted <==

2012 Highlights 2 Letter from the Chairman 4 Chief Executive Officer’s Report 8 Review of Operations and Activities 10 Directors 14 Senior Management 16 Directors’ Report 18 Remuneration Report 24 Corporate Governance Statement 32 Financial Statements 38 Notes to the Financial Statements 43 Directors‘ Declaration 74 Independent Auditor’s Report 75 Lead Auditor’s Independence Declaration 77 ASX Additional Information 78 Corporate Directory 81

2012 Highlights

Financial Summary

In millions of AUD (except earnings per share)

==> picture [484 x 176] intentionally omitted <==

----- Start of picture text -----

Year ended 30 June 2012 2011 % Change
Revenue from licence fees 28.9 25.0 Ç 15%
Total revenue 48.6 44.6 Ç 9%
Net profit after tax 9.0 7.5 Ç 21%
Net assets 29.2 27.4 Ç 7%
Cash at balance date 12.0 11.6 Ç 3%
Americas revenue 31.9 26.7 Ç 19%
Europe revenue 7.2 7.1 Ç 1%
Asia Pacific revenue 8.7 8.9 È 2%
Earnings per share (cents per share) 5.41 4.47 Ç 21%
----- End of picture text -----

In millions of local currency

==> picture [484 x 71] intentionally omitted <==

----- Start of picture text -----

Year ended 30 June 2012 2011 % Change
Americas revenue (USD) 33.1 26.5 Ç 25%
Europe revenue (UK Sterling) 4.7 4.4 Ç 6%
Asia Pacific revenue (AUD) 8.7 8.9 È 2%
----- End of picture text -----

Net profit after tax (AUD millions)

Revenue from licence sales (AUD millions)

Total revenue

(AUD millions)

==> picture [484 x 192] intentionally omitted <==

----- Start of picture text -----

$48.6 $9.0 $28.9
$44.6
$42.7 $7.9 $25.0
$7.5
$37.4 $38.2
$21.7
$19.6
$5.8 $18.4
$5.4
2008 2009 2010 2011 2012 2008 2009 2010 2011 2012 2008 2009 2010 2011 2012
----- End of picture text -----

==> picture [596 x 842] intentionally omitted <==

2 | Integrated Research and its controlled entities | Annual Report 2012

Letter from the Chairman | page 4 – 5

Letter from the Chairman

4

==> picture [52 x 163] intentionally omitted <==

==> picture [144 x 160] intentionally omitted <==

We support the changing needs of our customers today, and grow with those who will be our customers tomorrow.”

Dear fellow shareholders,

I’m very pleased to report another year of strong growth for Integrated Research for the financial year to June 2012. The Company continues to build on its solid foundation of world-class R&D through increases in its product lines, most noticeably the expansion of its VoIP product range into the management of Unified Communications, which approximately doubles the company’s addressable market.

evolution made significant progress as the Company expanded the number of supported platforms to include Microsoft Lync. The addition of the Microsoft Lync platform resulted in the largest sale the Company has ever recorded.

exceeded $50 million in underlying USD equivalents. In local currency the Americas grew by 25% with Europe up 6%. 2012 was a more difficult year for Asia Pacific, with revenue down 2%.

Despite the strength in the

Australian dollar which caused an adverse 4% appreciation against the US dollar, the Company achieved a 21% increase in annual after tax profit over the prior year to $9.0 million. Licence sales increased by 15% to $28.9 million, while total revenue increased by 9% to $48.6 million.

The Company’s Unified Communications (UC) products achieved a 26% increase in revenue to $21.4 million, becoming the Company’s highest revenue product line. Prognosis is wellpositioned to become a leading product in the rapidly evolving UC market. During FY 2012 this

Consulting services showed strong growth for the third year in a row, with revenue increasing by 26% to $3.3 million, representing 12% of new licence sales. This is primarily due to a closer alignment between product sales and consulting. The company will continue its focus

The Company derived 95% of its revenue from outside of Australia, with the Americas representing over 65% of total revenue. For the first time the Company revenue

on consulting and expects to increase the percentage of consulting revenue to sales in the ensuing years.

The Company’s financial results were further strengthened by strong growth in our Payments products, with licence sales up 60% on the prior year to $2.3 million while HP NonStop licence sales remained solid, showing a 2% increase.

The strong results in recent years are further validated by the growth in the Company’s customers, with the number of enterprise customers doubling in the last five years.

In the current environment, we are fortunate to be a company built on a number of strengths. Our core values are strong, and our business fundamentals are solid and improving; we generated robust cash flow from licences, maintenance and consulting. Integrated Research continues to maintain a strong financial position and remains free of debt with a total cash position at 30 June 2012 of $12.0 million.

With a healthy balance sheet, global reach and strong partner relationships and alliances the company is positioned for further solid growth, we hold leadership positions in both our traditional business line, HP Nonstop, and our emerging high-growth markets including Unified Communications.

The Board is pleased to announce a final dividend of 3.0 cents per share, franked to 70 per cent, bringing the total dividend for the year to 5.0 cents per share franked at 58%. This compares with total dividends of 4.0 cents per share, of which 65% was franked, for the prior financial year.

I would especially like to thank you our valued shareholders, customers and employees for your continued support.

==> picture [137 x 55] intentionally omitted <==

Steve Killelea

Chairman

4 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 5

IR: innovating solutions for our customers in global markets

Integrated Research is a global success story, with marketleading products and prominent customers all around the world. Our international network of offices, partnerships and strategic alliances allows us to support customers of any size – from small businesses to the largest enterprises, service providers and government departments.

As business conditions change and technologies advance, IR continues to optimise and enhance our products and services portfolio to ensure customers have the insight they need to run their business today and into the future.

Who we are

Integrated Research

IR is the leading global provider of Prognosis performance management solutions for Unified Communications, Payments and IT Infrastructure.

What we do

Capabilities

Prognosis provides availability and performance management, diagnostics and insight for mission-critical systems.

Why we succeed

Competitive Advantage

P Prognosis is real-time, scalable, extensible and flexible P Prognosis supports multiple platforms, vendors and applications P IR has 1,000 enterprise customers globally P IR has a world-class R&D capability P IR is profitable, debt-free and growing

Why customers buy

Value Proposition

Prognosis increases technology performance, minimises outages, reduces cost and ensures user satisfaction.

Annual Report 2012 | Integrated Research and its controlled entities | 7

Chief Executive Officer’s Report | page 8 – 9

8 Chief Executive Officer’s Report

==> picture [52 x 163] intentionally omitted <==

==> picture [144 x 160] intentionally omitted <==

With the growth in size, complexity and criticality of networks there is a greater need for real-time performance management than ever before.”

Dear Shareholders,

Integrated Research has once again delivered a strong performance. Revenue was up 9% to $48.6 million and profit after tax up 21% to $9.0 million.

Integrated Research is well positioned in high growth markets and the Company’s future is very promising.

The growth of revenue and profit in 2012 can be attributed to the successful execution of the Company’s strategy.

of communication including voice, video, messaging, mobility and presence. UC functionality increases the complexity of communications networks and the need for proactive management.

service. With over 1,000 enterprise customers, Prognosis has proven that it is ideally and uniquely suited to these environments.

This strategy continues to focus on the creation, sale and support of Prognosis-based products into the Unified Communications (UC), Payments and Infrastructure markets, as well as opening new high-growth markets.

As enterprises increasingly adopt UC, our strategy continues to yield results: UC is now the Company’s highest revenue product line. Sales rose 26% in 2012 and we added 156 new customers.

Projected growth for the UC market is significant, with Gartner[1] estimating that there will be 250 million UC endpoints by 2017. Each endpoint requires multiple UC applications to be managed, which increases the opportunity for Integrated Research.

UC market growth is fueled by a number of significant drivers: the ongoing rise in IP endpoints – accelerated now with the entry of Microsoft Lync – and the shift from Voice over IP (VoIP) to UC, which incorporates multiple methods

The size, criticality and increasing complexity of technology in these markets requires the scalable, real-time management capabilities of Prognosis to ensure their ongoing operation and quality of

Our Payments products also delivered encouraging revenue growth of 32%.

1 Source Gartner (June 2012) Forecast: Enterprise Telephony Equipment, Worldwide, 2007-2016, 2Q12 Update

The Company continues to invest in this market and our strategic partnership with ACI, as we develop and extend our monitoring solutions for wholesale payments and fraud detection.

The Payments market is projected to expand considerably, heightened by the demand on back-end processing, and increasing governance regulation and complexity. This means that effective performance management and monitoring are more vital than ever.

The Boston Consulting Group[2] estimates that global payments transaction volumes will more than double between 2010 and 2020. This growth is fueled by the rise in micro-payments, payments through new channels including the internet and mobile phones, and the growth of electronic payments in developing economies.

Revenue from our Infrastructure products, including the Company’s bedrock HP NonStop line, delivered a solid result of $20.5 million. HP NonStop licence sales grew 2% on last year, illustrating the ongoing need for the platform.

All of our product lines benefited from our Consulting services, helping customers implement Prognosis quicker and more effectively to meet their business needs.

Our success in 2012 and the strength of our markets mean that we will continue to invest in sales

2 Source BCG Report, Global Payments 2011, “Winning After the Storm”

and marketing in all regions to capture the opportunities there.

We have hired additional headcount in the Americas, we are expanding our presence in Germany to benefit from the strength of the strongest European economy, and we will open an office in Singapore to capture market share in Asia.

We will maintain our investment in R&D, at 21% of revenue, which is in-line with historical averages.

Our pervasive use of the Agile development methodology continues to deliver high quality products at greater levels of productivity. The productivity of our Australian cost base is particularly important given the high Australian dollar; it means we can produce innovative products very quickly to support our customers and stay ahead of competitors.

Our graduate program has once again provided a great pool of talent. By supporting the Australian education system and harnessing the latest ideas and enthusiasm we increase our R&D capability and help cement our position as a thriving market leader now and in the future.

I would like to thank our talented and hardworking staff for our results in FY12 and I look forward to working with them to deliver further growth for you in FY13.

Thank you for your support.

==> picture [140 x 49] intentionally omitted <==

Mark Brayan

Chief Executive Officer

8 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 9

Review of Operations and Activities | page 10 – 13

10 Review of Operations and Activities

Expenses

The Company continued to focus on expanding its capabilities and improving productivity. The number of staff at the end of the current year was 186 (2011: 162). Total expenses were $37.4 million, up 10% against the prior year with a higher investment in sales and marketing.

Research and development expenditure of $10.1 million was 21% of total revenue and in line with historical averages. The company is committed to maintaining and improving its core strategic strength and we expect a comparable level of investment in research and development in the future.

Net research and development expenses are represented as follows:

Principal activities

The Company’s principal activities during the year were the design, development, implementation and sale of systems and applications management computer software for business-critical computing and Unified Communication networks.

Group overview

Integrated Research has a twenty-four year heritage of providing performance monitoring and diagnostics software solutions for business-critical computing environments.

Since its establishment in 1988, the Company has provided its core Prognosis products to a cross section of large organisations requiring high levels of computing performance and reliability.

The Prognosis product range is an integrated suite of monitoring and management software, designed to give an organisation’s technical personnel operational insight into their HP NonStop, distributed system servers, Unified Communications (“UC”), and Payments environments and the business applications that run on these platforms.

The Company has developed its Prognosis products around a fault-tolerant, highly distributed software architecture, designed to achieve high levels of functionality, scalability and reliability with a low total cost of ownership.

Integrated Research services customers in more than 50 countries through direct sales offices in the USA, UK, Germany and Australia, and via a global, channel-driven distribution network. The Company’s customer base consists of many of the world’s largest organisations and includes major stock exchanges, banks, credit card companies, telecommunications companies, computer companies and hospitals.

Review and results of operations

The Company achieved a 21% increase in annual after tax profit over the prior year to $9.0 million, which is within the guidance provided to the Australian Stock Exchange on July 6, 2012. Total revenue increased by 9% over the prior year, to $48.6 million. The growth in revenue was brought about by strong licence sales in both Unified Communications and Payments product lines. In constant currency, revenue grew by 13% compared to the prior year.

Revenue

Revenue for the year was $48.6 million, an increase of 9% over 2011. Licence fees increased by 15% and whilst maintenance fees decreased by 3% over the prior year it increased by 2% using a constant currency. The customer retention rate was 91% for the year ending June 2012.

In underlying natural currency revenue grew in the Americas by 25% and Europe by 6%. Asia Pacific revenue was relatively flat compared to the prior year.

Revenue derived from the Company’s UC products continued its strong growth. Even with the stronger Australian dollar, new licence sales for UC were up 26% over the prior year with strong growth driven by the Americas.

Licence sales derived from HP NonStop remained stable with growth of 2% of the previous corresponding period. Revenue from consulting services increased by 26% over the prior year to $3.3 million and made a contribution of $0.7 million to the group results.

==> picture [489 x 97] intentionally omitted <==

----- Start of picture text -----

In thousands of AUD 2012 2011
Gross research and development spending 10,215 8,924
Capitalisation of development expenses (6,730) (5,655)
Amortisation of capitalised expenses 6,649 5,680
Net research and development expenses 10,134 8,949
----- End of picture text -----

Shareholder returns

Returns to shareholders increased through the payment of partly franked dividends:

==> picture [489 x 97] intentionally omitted <==

----- Start of picture text -----

2012 2011 2010
Net profit ($’000) $9,035 $7,465 $5,401
Basic EPS 5.41¢ 4.47¢ 3.24¢
Dividends per share 5.0¢ 4.0¢ 3.0¢
Return on equity 31% 27% 22%
----- End of picture text -----

Financial position

The consolidated entity continues to hold a strong financial position being free of debt and with cash at 30 June 2012 of $12.0 million, compared to $11.6 million at the same time last year. Net cash flow provided by operating activities increased 6% over the equivalent prior year to $14.6 million.

==> picture [489 x 80] intentionally omitted <==

----- Start of picture text -----

2012 2011 2010
Net cash flow provided by operating activities ($’000) $14,646 $13,854 $8,339
Current ratio (current assets to current liabilities) 1.93 1.80 1.57
Net tangible asset backing per ordinary share 9.18¢ 8.12¢ 6.32¢
----- End of picture text -----

The Company generates most of its revenue from licence fees, recurring maintenance and consulting services.

10 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 11

Outlook and Strategy for 2013

The Company provides performance management solutions based on its Prognosis software for missioncritical computing environments.

Prognosis derives its competitive advantage from its unique design which enables real time monitoring, is extremely scalable, highly flexible and provides very deep visibility into the systems and applications that it manages. As such, Prognosis is ideally suited to complex, high transaction and high traffic environments.

Through deep forensic analysis into the root cause of problems and extensive reporting on service levels, Prognosis enables proactive and rapid resolution of issues, and capacity and operational planning.

This provides insight into potential issues before they become business critical. Prognosis helps users improve their operational maturity by proactively minimising expensive outages, improving user satisfaction and optimising IT operations and resources.

The Company’s growth strategy is to create, sell and support Prognosis-based products and services that deliver profitable growth from existing markets and customers, as well as creating new products that open new markets.

The Company currently focuses on three core markets: Infrastructure, Communications and Payments.

The Infrastructure market for Integrated Research includes users of high-end computing systems such as the HP NonStop platform for financial, telecommunication, trading, manufacturing and other high-volume, high-value transaction environments. NonStop is an important part of HP’s server strategy and remains at the operational core of many of the world’s largest companies. The Company continues to invest in Prognosis for Nonstop to be aligned with HP and its customers. Prognosis for Distributed Systems (Windows, Unix and Linux) is mostly sold alongside the Company’s NonStop products as customers seek a common monitoring interface for all platforms, or convert applications from one platform to another.

The Communications segment includes users of IP Telephony and Unified Communications (UC) applications such as video, messaging, mobility and presence. The Company anticipates growth in this segment through the ongoing shipment of IP phones and endpoints as well as the increasing value per endpoint through the use of UC applications. UC networks are becoming more pervasive, more critical and more complex and as such they require effective performance management and Prognosis is strongly positioned to benefit from this need. The company will continue to invest in R&D to expand the suite of Prognosis for UC products to cover more platforms, vendors and applications, and by doing so increase the Company’s addressable market and revenue potential.

The Company has expanded its suite of Payments products by adding new products for additional platforms, vendors and applications, including fraud management and wholesale money transfer applications. This expands the company’s addressable market in the Payments segment and increases revenue potential. The Company will maintain this strategy in the Payments market. Our strategic alliance with ACI, the world’s largest payments software vendor, has delivered revenue in FY2012 and continues to be an important channel to market for the Company.

Consulting Services provide Prognosis customers with implementation, customisation and training services to ensure that they get the most out of their investment in Prognosis. Consulting Services also help IR develop unique and repeatable solutions that extend the use and value of Prognosis. Consulting Services achieved profitability in FY2012 and the Company will continue to invest in people and processes to grow consulting revenue and margin.

The Company continues to invest in its R&D capability through the addition of resources and its use of the Agile development methodology which has improved the rate and quality of software production for the Company.

==> picture [268 x 211] intentionally omitted <==

==> picture [268 x 212] intentionally omitted <==

==> picture [268 x 211] intentionally omitted <==

12 | Integrated Research and its controlled entities | Annual Report 2012

Directors and Senior Management | page 14 – 17

Directors

The directors of the Company at any time during or since the end of the financial year are listed below:

==> picture [105 x 145] intentionally omitted <==

==> picture [105 x 144] intentionally omitted <==

==> picture [105 x 145] intentionally omitted <==

Steve Killelea, AM

Non-Executive Director and Chairman

Steve founded Integrated Research in August 1988 and held the position of Managing Director and Chief Executive Officer until retiring from his executive position in November 2004. He was appointed as a NonExecutive Director in November 2004 and elected Chairman in July 2005. Steve is also Chairman of the Institute for Peace and Economics and The Charitable Foundation and for activities involved with these he has received a number of international awards. He is also active in the financial community with investments in many high tech companies. Steve’s current term will expire no later than the close of the 2012 Annual General Meeting. Listed companies directorships held in the past three years: None. Age: 63 years.

MBA Mark Brayan,

Managing Director and Chief Executive Officer

Mark Brayan joined Integrated Research in September 2007 and is responsible for the overall strategy and leadership of the Company. Mark has over twenty years’ experience in the software industry. Prior to joining Integrated Research he was COO of outsourcer Talent2 and previously CEO of the listed software company Concept Systems before its merger with Talent2. Mark has a strong understanding of the systems management market through his time with BMC Software. As Managing Director, Mark is not required to seek re-election to the Board.

Listed companies directorships held in the past three years: None. Age: 48 years.

Alan Baxter, BSc, DipEd

Independent Non-Executive Director

Alan was appointed as a Director in June 2009. Alan has over forty years’ experience in Information Technology covering a broad range of the industry’s activities. These include many years in a variety of roles with IBM Australia, CEO of DMR Consulting in Australia and COO of Fujitsu Consulting’s global operations from London. He was nonexecutive Chairman of Fujitsu Australia & New Zealand, a director of Mincom Ltd, non-executive Chairman of Konekt Limited and also of Innogence Limited. He is a non-executive director of CPT Global, a publicly listed technology consulting company. Alan’s current term will expire no later than the close of the 2012 Annual General Meeting. Listed company directorships held in the past three years other than listed above: None. Age: 67 years.

John Brown, BCom, FCA, MAICD Independent Non-Executive Director

John was appointed a Director in July 2007. He was a partner with KPMG for over 26 years and since retiring in 2006 has been appointed to be the chair or member of the audit committee of a number of NSW and Federal public sector entities. John is also a Director and Chair of the Audit Committee of Sydney Water Corporation, a member of the National Health and Research Medical Council and a Director of The Gift Of Life Foundation. John’s current term will expire no later than the close of the 2013 Annual General Meeting. Listed companies directorships held in the past three years: None. Age: 64 years.

==> picture [106 x 145] intentionally omitted <==

Kate Costello, LLB, FAICD Independent Non-Executive Director

Kate was appointed as a Director in August 2005. She is a lawyer and has over twenty years’ experience in corporate governance and strategy development. She is also a Director of Governance Matters Pty Ltd, listed company, LBT Innovations Ltd, and a number of other private companies. Kate’s current term will expire no later than the close of the 2014 Annual General Meeting.

Listed companies directorships held in the past three years other than listed above: None. Age: 59 years.

==> picture [106 x 145] intentionally omitted <==

Clyde McConaghy, BBus, MBA, MAICD, MIOD – UK Non-Executive Director

Clyde was appointed a Director in December 2007. He has two decades of international strategic market development experience in the technology, media and publishing industries. Clyde was a board director of WMRC Plc, an economic analysis publisher, on the London Stock Exchange and a director of the Economist Intelligence Unit in London. Clyde is managing director of Smarter Capital Pty Limited, another company associated with Mr Steve Killelea, Chairman of Integrated Research. Clyde’s current term will expire no later than the close of the 2014 Annual General Meeting.

Listed companies directorships held in the past three years: None. Age: 50 years.

==> picture [106 x 145] intentionally omitted <==

Peter Lloyd

Independent Non-Executive Director

Peter was appointed a Director in July 2010. He has 39 years’ experience in computing technology, having worked for both computer hardware and software solution providers. For the past 26 years Peter has been specifically involved in the provision of payments solutions for the financial services industry. Peter is currently the global sales and marketing Director for Distra Pty Ltd a provider of payments systems. He is also a Director of The Grayrock Group Pty Ltd and Limehouse Creative Pty Ltd. Peter’s current term will expire no later than the close of the 2013 Annual General meeting.

Listed companies directorships held in the past three years: None. Age: 58 years.

==> picture [40 x 54] intentionally omitted <==

David Purdue,

David Leighton,

BEc, MBA, GradDip CSP, FCA, FCIS, FCSA, GAICD Company Secretary

MBA, FCPA, ACIS

Company Secretary

David is a member of Chartered Secretaries Australia. David has been Company Secretary from October 2000 up to his retirement in July 2012.

David was appointed Company Secretary in July 2012. David is also the Company’s Global Commercial Manager and is responsible for the company’s global commercial business. Prior to this, David spent three years at Integrated Research’s Colorado office to manage the Americas finance operations. David is a qualified Chartered Accountant and Chartered Secretary with over 25 years’ experience in both professional practice and industry.

14 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 15

Directors and Senior Management | page 14 – 17

16 Senior Management

==> picture [105 x 145] intentionally omitted <==

Peter Adams, BCom, CA

Chief Financial Officer

Peter joined Integrated Research in March 2008 and is responsible for overseeing the Company’s finance and administration, including regulatory compliance and investor relations. Peter is a Qualified Chartered Accountant with over 25 years’ experience. He has held a number of senior accounting and finance roles, including seven years as CFO with Infomedia (an ASX-listed technology company), six years with Renison Goldfields (ex ASX top 100 Resources Company) and two years with Transfield Pty Ltd. Peter’s career began with Arthur Andersen, where he was responsible for managing large audit clients.

Alex Baburin, BAppSc

General Manager, Research and Development

Alex Baburin joined Integrated Research in November 2006 and is responsible for the Company’s software development and global support activities. Alex has over 25 years’ experience in the development, creation and management of high-technology hardware and software products for Honeywell and Siemens. Before joining Integrated Research he was responsible for general management of the Siemens Access Control product line globally and for much of that time was based in Germany.

Brian Bigley

Vice President Europe

Brian joined Integrated Research in September 2009 and was responsible for all business operations in Europe until recently returning to Integrated Research in the United States to take up a senior role. Brian has over 25 years of experience in the computer industry including Compaq Computer, Siemens, CA (previously known as Computer Associates), HP and start-ups as a sales and marketing executive. Brian has held CEO, President and Sr. Vice President roles during his career.

Andre Cuenin, BSc, MBA

President Americas

Andre joined Integrated Research in October 2008 and is responsible for all business operations in the Americas region. Andre has over 20 years’ experience in IT sales, most recently as VP of Field Operations at Stratavia, where he was responsible for sales and professional services marketing worldwide. Prior to this he spent 15 years with CA (previously known as Computer Associates) in several senior management positions including VP of Worldwide Sales Operations.

==> picture [106 x 145] intentionally omitted <==

John Dunne, BInfTech, MBT

General Manager, Products & Alliances

John is responsible for the company’s global product strategy and alliances, ensuring the delivery of high-quality products aligned to customers’ strategic directions. He is an expert in systems monitoring and management with over 15 years’ experience in the ICT industry, including eight years with Integrated Research. His current focus includes development of enterprise-class IP telephony management and reporting solutions to deliver business insight to global organisations and service providers.

Andrew Levido, BEng, MBA

General Manager, Global Sales

Andrew joined Integrated Research in May 2012 and is responsible for the global sales, pre-sales and consulting operations. He has over 25 years’ experience in leadership roles in the technology sector, including senior regional and global roles with Alcatel, Alcatel-Lucent and Technicolor. Andrew has extensive international experience and has lived and worked in various Asian and European countries.

Melanie Newman, HRM PGDip

General Manager, Human Resources

Melanie is responsible for the Human Resources function at Integrated Research which includes responsibility for aligning Strategic HR initiatives with the Business Strategy to support a high performance culture. Melanie has over 14 years’ HR Management experience mostly within global organisations in the Information Technology industry.

Pierre Semaan, BEng, MBA Vice President Asia Pacific

Pierre joined Integrated Research in May 2008 and is responsible for all business operations in the Asia Pacific region. Prior to taking over responsibilities for Asia Pacific in January 2011, Pierre was responsible for the management and strategic direction of all product lines at Integrated Research. Pierre has over 20 years international experience managing teams delivering technology innovations. He was most recently the Senior Vice President of Technology for Sage CRM solutions, which included leading the ACT!, SalesLogix and Mobility R&D organisations. Prior to Sage, Pierre worked at Citrix as the Chief of Operations & Director of the CTO Office and Advanced Products Group.

16 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 17

Directors’ Report | page 18 – 23

18 Directors’ Report

The directors present their report together with the Financial Statements of Integrated Research Limited (“the consolidated entity”), being the Company and its controlled entities, for the year ended 30 June 2012 and the Auditor’s Report thereon.

Results

The net profit of the consolidated entity for the 12 months ended 30 June 2012 after income tax expense was $9.0 million.

Dividends

Dividends paid or declared by the Company since the end of the previous financial year were:

Cents Per Share	Total Amount $’000	Date of Payment
Final 2011 – Ordinary shares 75% franked 2.5	4,172	16 Sep 2011
Interim 2012 – Ordinary shares 40% franked 2.0	3,340	16 Mar 2012
Final 2012 – Ordinary shares 70% franked 3.0	5,033	14 Sep 2012

Principal activities and review of operations

Detail of the principal activities and review of operations of the consolidated entity are set out on pages 10 to 12.

Events subsequent to reporting date

For dividends declared after 30 June 2012 see Note 19 in the financial statements. The financial effect of dividends declared and paid after 30 June 2012 has not been brought to account in the financial statements for the year ended 30 June 2012 and will be recognised in subsequent financial statements.

No other transaction or event of a material or unusual nature has arisen in the interval between the end of the financial year and the date of this report which is likely, in the opinion of the directors of the Company, to affect significantly the operations of the consolidated entity, the results of those operations, or the state of affairs of the consolidated entity, in future financial years.

Directors and company secretary

Details of current directors’ qualifications, experience, age and special responsibilities are set out on pages 14 to 15. Details of the company secretary and his qualifications are set out on page 15.

Officers who were previously partners of the audit firm

No officers of the Company during the financial year were previously partners of the current audit firm.

Directors’ meetings

The numbers of meetings of the Company’s board of directors and of each board committee held during the year ended 30 June 2012, and the numbers of meetings attended by each director were:

Board Meetngs	Audit and Risk Commitee Meetngs	Nominaton and Remuneraton Commitee Meetngs	Strategy Commitee Meetngs	Strategy Commitee Meetngs
A B	A B	A B	A	B
Alan Baxter 11 12	- -	5 5	-	-
Mark Brayan 12 12	- -	- -	4	4
John Brown 12 12	3 3	- -	-	-
Kate Costello 12 12	- -	4 5	4	4
Steve Killelea 10 12	- -	4 5	4	4
Peter Lloyd 12 12	3 3		4	4
Clyde McConaghy 12 12	3 3	- -	-	-

A: Number of meetings attended.

B: Number of meetings held during the time the directors held office or was a member of the board or committee during the year.

State of affairs

In the opinion of the directors there were no significant changes in the state of affairs of the consolidated entity that occurred during the financial year under review.

Environmental regulation

The consolidated entity’s operations are not subject to significant environmental regulations under either Commonwealth or State legislation.

Future developments

Likely developments in the operations of the consolidated entity in future financial years and the expected results of those operations are referred to generally in the Review of Operations and Activities Report.

Further information on likely developments including expected results would in the Directors’ opinion, result in unreasonable prejudice to the Company and has therefore not been included in this Report.

18 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 19

Directors’ Report | page 18 – 23

Directors’ interests

The relevant interest of each director in the shares, options or performance rights over ordinary shares issued by the companies in the consolidated entity and other relevant bodies corporate, as notified by the directors to the Australian Securities Exchange in accordance with S205G(1) of the Corporations Act 2001, at the date of this report is as follows:

==> picture [484 x 158] intentionally omitted <==

----- Start of picture text -----

Ordinary shares in Integrated Research Options Performance rights
Directly held Beneficially held Total Number of Options Number of Rights
Alan Baxter - 100,000 100,000 - -
Mark Brayan 250,000 25,000 275,000 750,000 170,000
John Brown 101,000 - 101,000 - -
Kate Costello - 200,000 200,000 - -
Steve Killelea 94,497,339 337,612 94,834,951 - -
- - - - -
Clyde McConaghy
- - - - -
Peter Lloyd
----- End of picture text -----

Share options and performance rights

Options and performance rights granted to directors and senior executives

On 21 November 2011, the consolidated entity established a new performance rights and options plan. Details of the plan are summarised in note 16 to the financial statements.

During or since the end of the financial year, the company granted performance rights for no consideration over unissued ordinary shares in Integrated Research Limited to the following named directors and executive officers of the consolidated entity as part of their remuneration:

==> picture [484 x 199] intentionally omitted <==

----- Start of picture text -----

Number of performance Exercise price Expiry date
rights granted
Directors
Mark Brayan 170,000 Nil Sep 2014
Executive Officers
Peter Adams 100,000 Nil Sep 2014
Alex Baburin 75,000 Nil Sep 2014
Brian Bigley 65,000 Nil Sep 2014
Andre Cuenin 75,000 Nil Sep 2014
John Dunne 75,000 Nil Sep 2014
Pierre Semaan 65,000 Nil Sep 2014
----- End of picture text -----

The performance rights were granted under the Integrated Research Performance Rights and Option Plan (established November 2011). The performance rights vest on 31 August 2014 subject to the consolidated entity achieving certain performance hurdles. The performance rights are automatically exercised upon vesting. The Company will issue shares upon vesting conditions being met for Executive Officers. The Company will make an on-market purchase for Mr Brayan upon his vesting conditions being satisfied.

Unissued shares under option and performance rights

Unissued ordinary shares of Integrated Research Limited under option or performance rights at the date of this report are as follows:

==> picture [483 x 156] intentionally omitted <==

----- Start of picture text -----

Options Performance Rights
Expiry date Exercise price Number of Expiry date Exercise price Number of
shares shares
Sep 2012 $0.42 750,000 Sep 2014 Nil 495,000
Mar 2013 $0.38 350,000 Nov 2014 Nil 869,500
July 2013 $0.35 200,000
Oct 2013 $0.31 340,000
May 2014 $0.28 735,000
Total options 2,375,000 Total performance rights 1,364,500
----- End of picture text -----

Options and performance rights do not entitle the holder to participate in any share issue of the Company or any other body corporate.

Shares issued on the exercise of options

During or since the end of the financial year, the Company issued ordinary shares as a result of the exercise of options as follows (there were no amounts unpaid on the shares issued):

Number of shares	Amount paid on each share
347,500	$0.28
327,000	$0.48
250,000	$0.42

Indemnification and insurance of officers and auditors

Indemnification

The Company has agreed to indemnify the directors of the Company on a full indemnity basis to the full extent permitted by law, for all losses or liabilities incurred by the director as an officer of the Company including, but not limited to, liability for negligence or for reasonable costs and expenses incurred, except where the liability arises out of conduct involving a lack of good faith.

Insurance

During the financial year Integrated Research Limited paid a premium to insure the directors and executive officers of the consolidated entity and related bodies corporate.

The liabilities insured include costs and expenses that may be incurred in defending civil or criminal proceedings that may be brought against officers in their capacity as officers of the consolidated entity.

The Company has not otherwise, during or since the financial year, indemnified or agreed to indemnify an officer or auditor of the Company or any related body corporate against a liability incurred as such on officer or auditor.

20 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 21

Remuneration report

The Company’s Remuneration Report, which forms part of this Directors’ Report, is on pages 24 to 31.

Corporate governance

A statement describing the Company’s main corporate governance practices in place throughout the financial year is on pages 32 to 37.

Non-audit services

During the year Deloitte Touche Tohmatsu, the Company’s auditor, has performed certain other services in addition to their statutory duties.

The board has considered the non-audit services provided during the year by the auditor and in accordance with written advice provided by resolution of the Audit & Risk Committee, is satisfied that the provision of those nonaudit services during the year by the auditor is compatible with, and did not compromise, the auditor independence requirements of the Corporations Act 2001 for the following reasons:

Æ All non-audit services were subject to the corporate governance procedures adopted by the Company and have been reviewed by the Audit & Risk Committee to ensure they do not impact the integrity and objectivity of the auditor, and
Æ The non-audit services provided do not undermine the general principles relating to auditor independence as set out in Professional Statement F1 Professional independence , as they did not involve reviewing or auditing the auditor’s own work, acting in a management or decision making capacity for the Company, acting as an advocate for the Company or jointly sharing risks and rewards.

A copy of the auditors’ independence declaration as required under Section 307C of the Corporations Act is on page 77 and forms part of the Directors’ Report.

Rounding of amounts to nearest thousand dollars

The Company is of a kind referred to in ASIC Class Order 98/100 dated 10 July 1998 and in accordance with that Class order, amounts in the Financial Statements and the Directors’ Report have been rounded off to the nearest thousand dollars, unless otherwise stated.

This report is made in accordance with a resolution of the directors.

==> picture [172 x 65] intentionally omitted <==

==> picture [135 x 63] intentionally omitted <==

Steve Killelea Chairman

Mark Brayan Chief Executive Officer

Dated at North Sydney this 21st day of August 2012

==> picture [268 x 211] intentionally omitted <==

==> picture [268 x 212] intentionally omitted <==

==> picture [268 x 211] intentionally omitted <==

22 | Integrated Research and its controlled entities | Annual Report 2012

Remuneration Report | page 24 – 31

Remuneration Report

Remuneration policies

Fixed remuneration

Remuneration levels for key management personnel and secretaries of the Company, and relevant key management personnel of the consolidated entity are competitively set to attract and retain appropriately qualified and experienced directors and senior executives. The Nomination and Remuneration Committee obtains independent advice on the appropriateness of remuneration packages given trends in comparative companies both locally and internationally and the objectives of the Company’s remuneration strategy.

Fixed remuneration consists of base remuneration (which is calculated on a total cost basis and includes any FBT charges related to employee benefits including motor vehicles), as well as employer contributions to superannuation funds.

Remuneration levels are reviewed annually through a process that considers individual, segment and overall performance of the consolidated entity. In addition, external remuneration surveys provide periodic analysis to ensure the directors’ and senior executives’ remuneration is competitive in the market place. A senior executive’s remuneration is also reviewed on promotion.

Key management personnel (including directors) have authority and responsibility for planning, directing and controlling the activities of the Company and the consolidated entity.

Performance-linked remuneration

The remuneration structures explained below are designed to attract suitably qualified candidates, reward the achievement of strategic objectives, and achieve the broader outcome of creation of value for shareholders. The remuneration structure takes into account:

Performance-linked remuneration includes both short-term and long-term incentives and is designed to reward executive directors and senior executives for exceeding their financial and personal objectives. The short-term incentive (STI) is an “at risk” bonus provided in the form of cash, while the long-term incentive (LTI) is provided as either options or performance rights over ordinary shares of Integrated Research Limited under the rules of the share plans.

Æ The capability and experience of the directors and senior executives
Æ The directors and senior executives ability to control the relevant segment’s performance
Æ The consolidated entity’s performance including:
Ì The consolidated entity’s earnings
Ì The growth in share price and returns on shareholder wealth

Remuneration packages include a mix of fixed and variable remuneration and short and long-term performance based incentives.

Short-term incentive bonus

The Nomination and Remuneration Committee is responsible for setting the key performance indicators (KPIs) for the Chief Executive Officer, and for approving the KPIs for the senior executives who report to him. The KPIs generally include measures relating to the consolidated entity, the relevant segment, and the individual, and include financial, people, customer, strategy and risk measures. The measures are chosen as they directly align the individual’s reward to the KPIs of the consolidated entity and to its strategy and performance.

The financial performance objectives vary with position and responsibility and are aligned with each respective year’s budget. The non-financial objectives vary with position and responsibility and include measures such as achieving strategic outcomes and staff development.

At the end of the financial year the Nomination and Remuneration Committee assesses the actual performance of the CEO against the KPIs set at the beginning of the financial year. A percentage of the predetermined maximum amounts for each KPI is awarded depending on results. The committee recommends the cash incentive to be paid to the CEO for approval by the board.

Long-term incentive

Prior to the 2012 financial year, options were issued to executive directors and other senior executives under the Employee Share Option Plan. In November 2011, the Company established a new plan titled Integrated Research Performance Rights and Options Plan (“IRPROP”). Performance rights are issued to executive directors and other senior executives under the IRPROP. The ability of executive directors and other senior executives to exercise either options or performance rights is conditional on the consolidated entity achieving certain profit after tax (PAT) performance hurdles over the vesting period. PAT was considered the most appropriate performance hurdle given its intrinsic link to creating shareholder wealth.

Consequences of performance on shareholder wealth

In considering the consolidated entity’s performance and benefits for shareholder wealth, the Nomination and Remuneration Committee has regard to the following indices in respect of the current financial year and the previous four financial years:

	2012	2011	2010	2009	2008
New licences	$28,861,000	$25,005,000	$18,413,000	$21,723,000	$19,623,000
Net proft	$9,035,000	$7,465,000	$5,401,000	$7,863,000	$5,776,000
Dividends paid	$7,512,000	$4,171,000	$7,506,000	$5,003,000	$5,826,000
Closing share price	$0.665	$0.275	$0.40	$0.275	$0.335
Change in share price	$0.39	($0.125) $0.125		($0.06) ($0.23)

Net profit and new licence sales are considered in setting the STI, as two of the financial performance targets are profit after tax and new licences.

The Nomination and Remuneration Committee considers that the above performance linked structure is generating the desired outcomes.

24 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 25

Remuneration Report | page 24 – 31

Key Management Personnel

The following were key management personnel of the consolidated entity at any time during the reporting period and unless otherwise indicated were key management personnel for the entire period:

Directors	Other key management personnel	Other key management personnel
(full year)	(full year)	(part year)
Steve Killelea Chairman	Peter Adams Chief Financial Ofcer	Geof Bryant Vice President Consultng
		(resigned Nov 2011)
Mark Brayan	Alex Baburin	Andrew Levido
Chief Executve Ofcer	General Manager,	General Manager, Global Sales
	Research and Development	(appointed May 2012)
Alan Baxter	Brian Bigley
	Vice President Europe
John Brown	Andre Cuenin
	President Americas
Kate Costello	John Dunne
	General Manager,
	Products and Alliances
Peter Lloyd	David Leighton
	Company Secretary
	(retred July 2012)
Clyde McConaghy	Pierre Semaan Vice President Asia Pacifc

Mr Peter Adams, Chief Financial Officer , has a contract of employment with Integrated Research Limited dated 23 January 2008, which provides for specific notice and severance undertakings of up to three months compensation depending on the particular circumstances. Mr Adams can terminate his employment by giving three months prior notice in writing.

Service agreements

Service contracts for executive directors and senior executives are unlimited in term but capable of termination by either party according to a period specified in the employment contract and the consolidated entity retains the right to terminate the contract immediately by payment in lieu of notice or a severance payment or an amount for redundancy equal to the scale of payments prescribed in the NSW Employment Protection Act.

Brian Bigley, Vice President Europe , has a contract of employment with Integrated Research Limited dated 1 November 2010, which provides for specific notice and severance undertakings of up to one month’s compensation depending on the particular circumstances. Mr Bigley can terminate his employment by giving one month’s prior notice in writing.

Mr Mark Brayan, Chief Executive Officer , has a contract of employment with Integrated Research Limited dated 29 August 2007, which provides for specific notice and severance undertakings of up to four months compensation depending on the particular circumstances. Mr Brayan can terminate his employment by giving four months prior notice in writing.

Mr Alex Baburin, General Manager Research and

Development , has a contract of employment with Integrated Research Limited dated 18 October 2006, which provides for specific notice and severance undertakings of up to one month’s compensation depending on the particular circumstances. Mr Baburin can terminate his employment by giving one month’s prior notice in writing.

Mr Andre Cuenin, President Americas , has a contract of employment with Integrated Research Limited dated 22 September 2008, which provides for specific notice and severance undertakings of one month’s compensation depending on the particular circumstances. Mr Cuenin can terminate his employment by giving one month’s prior notice in writing.

Mr John Dunne, General Manager Products and

Alliances , has a contract of employment with Integrated Research Limited dated 29 August 2008, which provides for specific notice and severance undertakings of one month’s compensation depending on the particular circumstances. Mr Dunne can terminate his employment by giving one month’s prior notice in writing.

Mr Andrew Levido, General Manager Global Sales , has a contract of employment with Integrated Research Limited dated 7 May 2012, which provides for specific notice and severance undertakings of three months compensation depending on the particular circumstances. Mr Levido can terminate his employment by giving three months prior notice in writing.

Mr Pierre Semaan, Vice President Asia Pacific , has a contract of employment with Integrated Research Limited dated 22 May 2008, which provides for specific notice and severance undertakings of one month’s compensation depending on the particular circumstances. Mr Semaan can terminate his employment by giving one month’s prior notice in writing.

Non-executive directors

Total remuneration for all non-executive directors last voted upon at a special meeting of shareholders in October 2000 is not to exceed $500,000 per annum.

Director’s base fees in FY2012 were $50,000 per annum plus compulsory superannuation. The chairman receives the base fee by a multiple of two. Director’s fees cover all main board activities and committee membership. Directors can elect to salary sacrifice their directors fees into superannuation.

Directors’ and executive officers’ remuneration

Details of the nature and amount of each major element of the remuneration of each of the key management personnel director of the Company and each of the executives and relevant group key management executives are reported below.

The estimated value of options and performance rights disclosed is calculated at the date of grant using the Binomial option pricing model, adjusted to take into account the inability to exercise options during the vesting period. Further details of options and performance rights granted during the year are set out below.

“Executive officers” are officers who are involved in, or who take part in, the management of the affairs of Integrated Research Limited and/or related bodies corporate. Remuneration for overseas-based employees has been translated to Australian dollars at the average exchange rates for the year.

No director or executive appointed during the year received a payment as part of his or her consideration for agreeing to hold the position.

Non-executive directors do not receive performance related compensation or retirement benefits.

26 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 27

Remuneration Report | page 24 – 31

==> picture [484 x 573] intentionally omitted <==

----- Start of picture text -----

Share- Other
Post- based compen- Proportion of
Short Term employment payments sation remuneration
Non- Super- Value of Termi- Value of
Salary cash annuation options nation Perfor- options
& fees Bonus benefits contribution and rights benefit Total mance and
2012 in AUD $ $ $ $ $ $ $ related rights
Directors: Non-executive
Alan Baxter 9,500 - - 45,000 - - 54,500 - -
John Brown 50,000 - - 4,500 - - 54,500 - -
Kate Costello 50,000 - - 4,500 - - 54,500 - -
- - - - - -
Peter Lloyd 50,000 4,500 54,500
Steve Killelea
- - - - - -
(Chairman) 100,000 9,000 109,000
- - - - - -
Clyde McConaghy 50,000 4,500 54,500
Directors: Executive
Mark Brayan 429,693 109,450 4,532 15,775 20,642 - 580,092 19% 4%
Executive officers (excluding directors)
Peter Adams 252,693 50,226 4,532 15,775 8,342 - 331,568 15% 3%
Alex Baburin 231,193 37,762 - 20,807 3,519 - 293,281 13% 1%
Brian Bigley 175,603 68,804 - 673 2,353 - 247,433 28% 1%
Geoff Bryant
(resigned
Nov 2011) 133,290 13,115 7,219 10,138 - - 163,762 8% -
Andre Cuenin 206,250 200,549 - 2,813 8,748 - 418,360 48% 2%
John Dunne 189,908 36,314 - 17,092 4,073 - 247,387 15% 2%
- - - - - -
David Leighton 45,000 4,050 49,050
Andrew Levido
(appointed
May 2012) 30,838 - 378 1,992 - - 33,208 - -
Pierre Semaan 219,693 89,467 4,532 15,775 4,725 - 334,192 27% 1%
Total
compensation:
key management
(consolidated,
including directors) 2,223,661 605,687 21,193 176,890 52,402 3,079,833
----- End of picture text -----

==> picture [483 x 597] intentionally omitted <==

----- Start of picture text -----

Share- Other
Post- based compen- Proportion of
Short Term employment payments sation remuneration
Non- Super- Value of Termi- Value of
Salary cash annuation options nation Perfor- options
& fees Bonus benefits contribution and rights benefit Total mance and
2011 in AUD $ $ $ $ $ $ $ related rights
Directors: Non-executive
Alan Baxter 29,750 - - 24,750 - - 54,500 - -
John Brown 50,000 - - 4,500 - - 54,500 - -
Kate Costello 50,000 - - 4,500 - - 54,500 - -
- - - - - -
Peter Lloyd 50,000 4,500 54,500
Steve Killelea
- - - - - -
(Chairman) 100,000 9,000 109,000
- - - - - -
Clyde McConaghy 50,000 4,500 54,500
Directors: Executive
Mark Brayan 395,468 130,600 4,532 15,199 (12,656) - 533,143 24% (2%)
Executive officers (excluding directors)
Peter Adams 241,007 45,874 4,532 15,199 (5,991) - 300,621 15% (2%)
Alex Baburin 220,183 37,374 - 19,817 (4,057) - 273,317 14% (1%)
Geoff Bryant 180,676 47,941 11,984 16,350 - - 256,951 19% -
Rick Ferguson
(resigned
Jan 2011) 138,322 40,019 2,644 13,886 (13,170) - 181,701 22% (7%)
- - - - - -
David Leighton 45,000 4,050 49,050
Pierre Semaan 221,007 95,302 4,813 15,199 (1,579) - 334,742 28% -
Andre Cuenin 207,999 286,522 - 2,985 1,514 - 499,020 57% -
John Dunne
(appointed
Jan 2011) 91,743 20,000 - 8,257 (140) - 119,860 17% -
Brian Bigley
(appointed
Nov 2010) 118,325 166,807 - - - - 285,132 59% -
Total
compensation:
key management
(consolidated,
-
including directors) 2,189,480 870,439 28,505 162,692 (36,079) 3,215,037
----- End of picture text -----

28 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 29

Remuneration Report | page 24 – 31

Analysis of bonuses included in remuneration

Details of the vesting profile of the short-term incentive cash bonuses awarded as remuneration to each director of the Company and each of the named Company executives and relevant group executives are detailed below:

==> picture [484 x 237] intentionally omitted <==

----- Start of picture text -----

Short term incentive bonuses
Included in remuneration % vested in year % forfeited in year
$ (A) (B)
Directors
Mark Brayan 109,450 50% 50%
Executives
Peter Adams 50,226 91% 9%
Alex Baburin 37,762 83% 17%
Brian Bigley 68,804 50% 50%
Geoff Bryant 13,115 52% 48%
Andre Cuenin 200,549 100% -
John Dunne 36,314 86% 14%
Pierre Semaan 89,467 63% 37%
----- End of picture text -----

(A) Amounts included in remuneration for the financial year represents the amount that vested in the financial year based on achievement of personal goals and satisfaction of specified performance criteria. No amounts vest in future financial years in respect of the short-term incentive bonus scheme for the 2012 financial year.
(B) The amounts forfeited are due to the performance or service criteria not being met in relation to the current financial year.

Equity instruments

All options refer to options over ordinary shares of Integrated Research Limited, which are exercisable on a one-forone basis under the Employee Share Option Plan (ESOP).

Options and rights over equity instruments granted as compensation

No options have been granted to named executives either during or since the end of the financial year.

All options expire on the earlier of their expiry date or termination of the individual’s employment, except for termination due to retirement. The options are exercisable on an annual basis on the first to fourth anniversaries of the grant date. In addition to a continuing employment service condition, the ability of executives to exercise options is conditional on the consolidated entity achieving certain performance hurdles.

Further details, including grant dates and exercise dates regarding options granted to executives under the ESOP are in Note 16 to the financial statements.

Exercise of options granted as compensation

During the reporting year no shares were issued to executives on the exercise of options previously granted as compensation.

Analysis of options and rights over equity instruments granted as compensation Details of vesting profile of the options granted to each director of the Company and each of the named executives are detailed below:

==> picture [483 x 226] intentionally omitted <==

----- Start of picture text -----

Options granted Value yet to vest ($)
Number Date Percent Percent Financial Min (B) Max (C)
vested in Forfeited in year in
year year (A) which grant
expires
Directors
Mark Brayan 1,000,000 Sep 2007 25% - 2013 nil nil
Executives
Peter Adams 350,000 Mar 2008 25% - 2013 nil nil
Alex Baburin 40,000 Oct 2008 25% - 2013 nil 1,254
Andre Cuenin 300,000 Oct 2008 25% - 2013 nil 9,405
Pierre Semaan 200,000 Jul 2008 25% - 2013 nil nil
John Dunne 30,000 May 2009 25% - 2014 nil 887
----- End of picture text -----

==> picture [483 x 253] intentionally omitted <==

----- Start of picture text -----

Performance rights Value yet to vest ($)
granted
Number Date Percent Percent Financial Min (B) Max (C)
vested in Forfeited in year in
year year (A) which grant
expires
Directors
Mark Brayan 170,000 Dec 2011 - - 2015 nil 65,212
Executives
Peter Adams 100,000 Dec 2011 - - 2015 nil 38,360
Alex Baburin 75,000 Dec 2011 - - 2015 nil 28,770
Brian Bigley 65,000 Dec 2011 - - 2015 nil 24,934
Andre Cuenin 75,000 Dec 2011 - - 2015 nil 28,770
Pierre Semaan 65,000 Dec 2011 - - 2015 nil 24,934
John Dunne 75,000 Dec 2011 - - 2015 nil 28,770
----- End of picture text -----

(A) The percentage forfeited in the year represents the reduction from the maximum number of options available to vest due to the performance hurdles not being achieved or due to the resignation of the executive.
(B) The minimum value of options yet to vest is $nil as the executives may not achieve the required performance hurdles or may terminate their employment prior to vesting.
(C) The maximum values presented above are based on the values calculated using the Binomial option pricing model as applied in estimating the value of options or performance rights for employee benefit expense purposes.

30 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 31

Corporate Governance Statement | page 32 – 37

32 Corporate Governance Statement

This statement outlines the main corporate governance practices that were in place throughout the financial year, which comply with the ASX Corporate Governance Council recommendations, unless otherwise stated.

The agenda for its meetings is prepared in conjunction with the chairman, chief executive officer and company secretary. Standing items include strategic matters for discussion, the CEO’s report, financial reports, key performance indicator reports and presentations by key executives and external industry experts. Board papers are circulated in advance. Directors have other opportunities, including visits to operations, for contact with a wider group of employees.

Board of directors and its committees

Role of the board

The board’s primary role is the protection and enhancement of long-term shareholder value.

To fulfil this role, the board is responsible for the overall corporate governance of the consolidated entity including evaluating and approving its strategic direction, approving and monitoring capital expenditure, setting remuneration, appointing, removing and creating succession policies for directors and senior executives, establishing and monitoring the achievement of management goals and assessing the integrity of internal control and management information systems. It is also responsible for approving and monitoring financial and other reporting.

Director education

The consolidated entity follows an induction process to educate new directors about the nature of the business, current issues, the corporate strategy and expectations of the consolidated entity concerning performance of directors. In addition executives make regular presentations to the board to ensure its familiarity with operational matters. Directors are expected to access external continuing education opportunities to update and enhance their skills and knowledge.

Board process

To assist in the execution of its responsibilities, the Board has established a number of board committees including a Nomination and Remuneration Committee, an Audit and Risk Committee and a Strategy Committee. These committees have written mandates and operating procedures, which are reviewed on a regular basis. The board has also established a framework for the management of the consolidated entity including board-endorsed policies, a system of internal control, a business risk management process and the establishment of appropriate ethical standards.

Independent advice and access to company information

Each director has the right of access to all relevant company information and to the company’s executives and, subject to prior consultation with the chairman, may seek independent professional advice from a suitably qualified adviser at the consolidated entity’s expense. A copy of the advice received by the director is made available to all other members of the board.

The full board currently holds twelve scheduled meetings each year and any extraordinary meetings at such other times as may be necessary to address any specific matters that may arise.

Composition of the board

The names of the directors of the company in office at the date of this report are set out on pages 14 to 15 of this report.

The company’s constitution provides for the board to consist of between three and twelve members. At 30 June 2012 the board members were comprised as follows:

Æ Mr Steve Killelea – Non Executive Director (Chairman).
Æ Mr Alan Baxter – Independent Non Executive Director.
Æ Mr John Brown – Independent Non Executive Director.
Æ Ms Kate Costello – Independent Non Executive Director.
Æ Mr Peter Lloyd – Independent Non Executive Director.
Æ Mr Clyde McConaghy – Non Executive Director.
Æ Mr Mark Brayan – Executive Director (Chief Executive Officer).

The election of Mr Killelea, who holds a majority of the company’s issued shares, as non-executive chairman, does not comply with the ASX Corporate Governance Council recommendation that the chairman be an independent director. However, the board is satisfied that the company benefits from Mr Killelea’s experience and knowledge gained through his long involvement with Integrated Research and his associations throughout the information industry. Mr Killelea founded Integrated Research in 1988 and was the CEO and managing director of the company until his retirement in November 2004.

At each Annual General Meeting one-third of directors, any director who has held office for three years and any director appointed by directors in the preceding year must retire, then being eligible for re-election. The CEO is not required to retire by rotation.

The composition of the board is reviewed on a regular basis to ensure that the board has the appropriate mix of expertise and experience. When a vacancy exists, through whatever cause, or where it is considered that the board would benefit from the services of a new director with particular skills, the Nomination and Remuneration Committee, in conjunction with the board, determines the selection criteria for the position based on the skills deemed necessary for the board to best carry out its responsibilities. The committee then selects a panel of candidates and the board appoints the most suitable candidate who must stand for election at the next general meeting of shareholders.

Nomination and Remuneration Committee

The Nomination and Remuneration Committee is a committee of the board of directors and is empowered by the board to assist it in fulfilling its duties to shareholders and other stakeholders. In general, the committee has responsibility to: 1) ensure the company has appropriate remuneration policies designed to meet the needs of the company and to enhance corporate and individual performance and 2) review board performance, select and recommend new directors to the board and implement actions for the retirement and re-election of directors.

Responsibilities regarding remuneration

The Committee reviews and makes recommendations to the board on:

Æ The appointment, remuneration, performance objectives and evaluation of the chief executive officer.
Æ The remuneration packages for senior executives.
Æ The company’s recruitment, retention and termination policies and procedures for senior executives.
Æ Executive remuneration and incentive policies.
Æ Policies on employee incentive plans, including equity incentive plans.
Æ Superannuation arrangements.
Æ The remuneration framework and policy for nonexecutive directors.
Æ Remuneration levels are competitively set to attract and retain the most qualified and experienced directors and senior executives. The Remuneration Committee obtains independent advice on the appropriateness of remuneration packages, given trends in comparative companies and industry surveys. Remuneration packages include a mix of fixed remuneration, performance-based remuneration and equity-based remuneration

32 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 33

Corporate Governance Statement | page 32 – 37

Responsibilities regarding nomination The Committee develops and makes recommendations to the board on:

Æ The CEO and senior executive succession planning
Æ The range of skills, experience and expertise needed on the board and the identification of the particular skills, experience and expertise that will best complement board effectiveness.
Æ A plan for identifying, reviewing, assessing and enhancing director competencies.
Æ Board succession plans to maintain a balance of skills, experience and expertise on the board.
Æ Evaluation of the board’s performance.
Æ Appointment and removal of directors.
Æ Appropriate composition of committees.

The terms and conditions of the appointment of non-executive directors are set out in a letter of appointment, including expectations for attendance and preparation for all board meetings, expected time commitments, procedures when dealing with conflicts of interest, and the availability of independent professional advice.

The members of the Nomination and Remuneration Committee during the year were:

Æ Ms Kate Costello (Chairperson) – Independent Non-Executive
Æ Mr Alan Baxter – Independent Non-Executive
Æ Mr Steve Killelea – Non-Executive

The Nomination and Remuneration Committee meets at least twice a year and as required. The Committee met five times during the year under review.

Audit and Risk Committee

The Audit and Risk Committee has a documented charter, approved by the board. All members must be non-executive directors with a majority being independent. The chairman may not be the chairman of the board. The committee advises on the establishment and maintenance of a framework of risk management and internal control of the consolidated entity.

The members of the Audit and Risk Committee during the year were:

Æ Mr John Brown (Chairman) – Independent Non-Executive
Æ Mr Peter Lloyd – Independent Non-Executive
Æ Mr Clyde McConaghy – Non-Executive

During the year, the Audit and Risk Committee provided the Board with updates to the Company’s risk management register (with the Board approving this document).

The external auditor, Chief Executive Officer and Chief Financial Officer are invited to Audit and Risk Committee meetings at the discretion of the committee. The committee met three times during the year and committee members’ attendance record is disclosed in the table of directors’ meetings on page 19.

The external auditor met with the audit committee/ board three times during the year, two of which included time without the presence of executive management. The Chief Executive Officer and the Chief Financial Officer declared in writing to the board that the company’s financial reports for the year ended 30 June 2012 comply with accounting standards and present a true and fair view, in all material respects, of the company’s financial condition and operational results. This statement is required annually.

The main responsibilities of the Audit and Risk Committee include:

Æ Serve as an independent party to monitor the financial reporting process and internal control systems.
Æ Review the performance and independence of the external auditors and make recommendations to the board regarding the appointment or termination of the auditors.
Æ Review the scope and cost of the annual audit, negotiating and recommending the fee for the annual audit to the board.
Æ Review the external auditor’s management letter and responses by management.
Æ Provide an avenue of communication between the auditors, management and the board.
Æ Monitor compliance with all financial statutory requirements and regulations.
Æ Review financial reports and other financial information distributed to shareholders so that they provide an accurate reflection of the financial health of the company.
Æ Monitor corporate risk management and assessment processes, and the identification and management of strategic and operational risks.
Æ Enquire of the auditors of any difficulties encountered during the audit, including any restrictions on the scope of their work, access to information or changes to the planned scope of the audit.

The Audit and Risk Committee reviews the performance of the external auditors on an annual basis and normally meets with them during the year as follows:

Æ To discuss the external audit plans, identifying any significant changes in structure, operations, internal controls or accounting policies likely to impact the financial statements and to review the fees proposed for the audit work to be performed.
Æ Prior to announcement of results:
Ì To review the half-year and preliminary final report prior to lodgement with the ASX, and any significant adjustments required as a result of the auditor’s findings.
Ì To recommend the Board approval of these documents.
Æ To finalise half-year and annual reporting:
Ì Review the results and findings of the auditor, the adequacy of accounting and financial controls, and to monitor the implementation of any recommendations made.
Ì Review the draft financial report and recommend board approval of the financial report.
Æ As required, to organise, review and report on any special reviews or investigations deemed necessary by the board.

Strategy Committee

The Strategy Committee has a documented charter, approved by the board and is responsible for reviewing strategy and recommending strategies to the board to enhance the company’s long-term performance. The committee is comprised of at least three members, including the chairman of the board and the Chief Executive Officer. The board appoints a member of the committee to be chairman.

The members of the Strategy Committee during the year were:

Æ Mr Steve Killelea (Chairman) – Non-Executive
Æ Mr Mark Brayan – Executive
Æ Mr Peter Lloyd – Independent Non-Executive
Æ Ms Kate Costello – Independent Non-Executive

The Strategy Committee is responsible for:

Æ Review and assist in defining current strategy.

Æ Assess new strategic opportunities, including M&A proposals and intellectual property developments or acquisitions.

Æ Stay close to the business challenges and monitor operational implementation of strategic plans.
Æ Endorse strategy and business cases for consideration by the full board.

The Committee met four times during the year under review.

Risk management

Under the Audit and Risk Charter, the Audit and Risk Committee reviews the status of business risks to the consolidated entity through integrated risk management programs ensuring risks are identified, assessed and appropriately managed and communicated to the board. Major business risks arise from such matters as actions by competitors, government policy changes and the impact of exchange rate movements.

Comprehensive policies and procedures are established such that:

Æ Capital expenditure above a certain size requires Board approval.
Æ Financial exposures are controlled, including the use of forward exchange contracts.
Æ Risks are identified and managed, including internal audit, privacy, insurances, business continuity and compliance.
Æ Business transactions are properly authorised and executed.

The Chief Executive Officer and the Chief Financial Officer have declared, in writing to the board that the company’s financial reports are founded on a sound system of risk management and internal compliance and control which implements the policies adopted by the board.

34 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 35

Corporate Governance Statement | page 32 – 37

Internal control framework

The board is responsible for the overall internal control framework, but recognises that no cost effective internal control system will preclude all errors and irregularities. The board has instigated the following internal control framework:

Æ Financial reporting – Monthly actual results are reported against budgets approved by the directors and revised forecasts for the year are prepared monthly.
Æ Continuous disclosure – Identify matters that may have a material effect on the price of the Company’s securities, notify them to the ASX and post them to the Company’s website.
Æ Quality and integrity of personnel – Formal appraisals are conducted at least annually for all employees.
Æ Investment appraisals – Guidelines for capital expenditure include annual budgets, detailed appraisal and review procedures and levels of authority.

Internal audit

The Company does not have an internal audit function but utilises its financial resources as needed to assist the board in ensuring compliance with internal controls.

Ethical standards

All directors, managers and employees are expected to act with the utmost integrity and objectivity, striving at all times to enhance the reputation and performance of the consolidated entity. Every employee has a nominated supervisor to whom they may refer any issues arising from their employment.

Conflict of interest

Each Director must keep the board advised, on an ongoing basis, of any interest that could potentially conflict with those of the Company. Where the board considers that a significant conflict exists the director concerned does not receive the relevant board papers and is not present at the meeting whilst the item is considered. The board has developed procedures to assist directors to disclose potential conflicts of interest. Details of director related entity transactions with the consolidated entity are set out in Note 25.

Code of conduct

The consolidated entity has advised each director, manager and employee that they must comply with the code of conduct. The code aligns behaviour of the board and management with the code of conduct by maintaining appropriate core values and objectives. It may be reviewed on the company’s website and includes:

Æ Responsibility to the community and fellow employees to act with honesty and integrity, and without prejudice.
Æ Compliance with laws and regulations in all areas where the company operates, including employment opportunity, occupational health and safety, trade practices, fair dealing, privacy, drugs and alcohol, and the environment.
Æ Dealing honestly with customers, suppliers and consultants.
Æ Ensuring reports and other information are accurate and timely.
Æ Proper use of company resources, avoidance of conflicts of interest and use of confidential or proprietary information.

Equal Employment Opportunity

The Company has a policy on Equal Employment Opportunity with the provision that commits to a workplace that is free of discrimination of all types. It is Company policy to hire, develop and promote individuals solely on the basis of merit and their ability to perform without prejudice to race, colour, creed, national origin, religion, gender, age, disability, sexual orientation, marital status, membership or non membership of a trade union, status of employment (whether full or part-time) or any other factors prohibited by law. The board is satisfied that the Equal Employment Opportunity policy is sufficient without the need to further establish a separate policy on gender diversity as required by the ASX Corporate Governance Council recommendation.

Trading in company securities by directors and employees

Directors and employees may acquire shares in the company, but are prohibited from dealing in company shares whilst in possession of price sensitive information, and except in the periods:

Æ From 24 hours to 28 days after the release of the company’s half-yearly results announcement or following the wide dissemination of information on the status of the corporation and current results.
Æ From 24 hours after the release of the company’s annual results announcement to a maximum of 28 days after the annual general meeting.

Directors must obtain the approval of the Chairman of the board and notify the Company Secretary before they buy or sell shares in the company, subject to board veto. The company advises the ASX of any transactions conducted by directors in shares in the company.

Communication with shareholders

The board provides shareholders with information using a comprehensive continuous disclosure policy which includes identifying matters that may have a material effect on the price of the company’s securities, notifying them to the ASX, posting them on the company’s website (www.ir.com), and issuing media releases. Disclosures under this policy are in addition to the periodic and other disclosures required under the ASX Listing Rules and the Corporations Act. More details of the policy are available on the company’s website.

The Chief Executive Officer and the Chief Financial Officer are responsible for interpreting the Company’s policy and where necessary informing the board. The Company Secretary is responsible for all communication with the ASX.

The board encourages full participation of shareholders at the Annual General Meeting to ensure a high level of accountability and identification with the consolidated entity’s strategy and goals. Important issues are presented to the shareholders as single resolutions. The external auditor is requested to attend the Annual General Meetings to answer any questions concerning the audit and the content of the auditor’s report.

The shareholders are requested to vote on the appointment and aggregate remuneration of directors, the granting of options and shares to directors, the Remuneration Report and changes to the Constitution. Copies of the Constitution are available to any shareholder who requests it.

36 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 37

Financial Statements | page 38 – 73

38 Financial Statements

Page

Contents	Contents	Page
Consolidated statement of comprehensive income		39
Consolidated statement of fnancial positon		40
Consolidated statement of changes in equity		41
Consolidated statement of cash fows		42
Notes to the fnancial statements		43
01.	Signifcant accountng policies	43
02.	Segment reportng	50
03.	Finance income	51
04.	Expenses	51
05.	Auditors’ remuneraton	51
06.	Income tax expense	52
07.	Earningsper share	52
08.	Cash and cash equivalents	53
09.	Trade and other receivables	53
10.	Other current assets	54
11.	Other fnancial assets	55
12.	Property, plant and equipment	55
13.	Deferred tax assets and liabilites	56
14.	Intangible assets	57
15.	Trade and otherpayables	59
16.	Employee benefts	59
17.	Provisions	62
18.	Other liabilites	62
19.	Capital and reserves	63
20.	Financial instruments	64
21.	Operatngleases	67
22.	Consolidated enttes	67
23.	Reconciliaton of cash fows from operatngactvites	68
24.	Keymanagementpersonnel disclosures	68
25.	Relatedpartes	72
26.	Parent enttydisclosures	73
27.	Subsequent events	73

Consolidated statement of comprehensive income

For the year ended 30 June 2012

==> picture [483 x 596] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD Notes 2012 2011
Revenue
Revenue from licence fees 28,861 25,005
Revenue from maintenance fees 16,406 16,941
Revenue from consulting 3,341 2,646
Total revenue 48,608 44,592
Research and development expenses (10,134) (8,949)
Sales, consulting and marketing expenses (23,004) (21,023)
General and administration expenses (4,278) (4,137)
Total expenses 4 (37,416) (34,109)
Other gains and losses
Currency exchange losses (133) (1,170)
Profit before finance income and tax 11,059 9,313
Finance income 3 509 381
Profit before tax 11,568 9,694
Income tax expense 6 (2,533) (2,229)
Profit for the year 9,035 7,465
Other comprehensive income
(Loss)/gain on cash flow hedge taken to equity (147) 287
Foreign exchange translation differences 125 (602)
Income tax relating to gains/(loss) on cash flow hedge 13 - (42)
Other comprehensive income (net of tax) (22) (357)
Total comprehensive income for the year 9,013 7,108
Profit attributable to:
Owners of the parent 9,035 7,465
Total comprehensive income attributable to:
Owners of the parent 9,013 7,108
Basic earnings per share (AUD cents) 7 5.41¢ 4.47¢
Diluted earnings per share (AUD cents) 7 5.38¢ 4.47¢
----- End of picture text -----

The consolidated statement of comprehensive income is to be read in conjunction with the notes to the financial statements set out on pages 43 to 73.

38 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 39

Financial Statements | page 38 – 73

Consolidated statement of financial position

As at 30 June 2012

==> picture [484 x 613] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD Notes 2012 2011
Current assets
Cash and cash equivalents 8 12,038 11,635
Trade and other receivables 9 20,725 14,058
Current tax assets 163 715
Other current assets 10 953 1,129
Total current assets 33,879 27,537
Non-current assets
Trade and other receivables 9 656 1,018
Other financial assets 11 1,802 1,800
Property, plant and equipment 12 1,820 1,875
Deferred tax assets 13 453 286
Intangible assets 14 13,849 13,808
Total non-current assets 18,580 18,787
Total assets 52,459 46,324
Current liabilities
Trade and other payables 15 4,285 3,365
Provisions 17 1,779 1,528
Income tax liabilities 1,653 1,664
Other current liabilities 18 9,832 8,737
Total current liabilities 17,549 15,294
Non-current liabilities
Deferred tax liabilities 13 3,003 2,605
Provisions 17 621 528
Other non-current liabilities 18 2,053 540
Total non-current liabilities 5,677 3,673
Total liabilities 23,226 18,967
Net assets 29,233 27,357
Equity
Issued capital 19 1,175 845
Reserves 19 (1,507) (1,495)
Retained earnings 29,565 28,007
Total equity 29,233 27,357
----- End of picture text -----

Consolidated statement of changes in equity

For the year ended 30 June 2012

==> picture [483 x 488] intentionally omitted <==

----- Start of picture text -----

Consolidated
Share Hedging Translation Employee Retained Total
In thousands of AUD capital reserve reserve benefit reserve earnings
Balance at 1 July 2011 845 147 (1,908) 266 28,007 27,357
- - - -
Profit for the year 9,035 9,035
Other comprehensive
income for the year
(net of tax) - (147) 125 - - (22)
Total comprehensive
income for the year - (147) 125 - 9,035 9,013
Lapsed employee options - - - (35) 35 -
44 - 44
Expensed employee options
Expensed employee
performance rights - - - 83 - 83
Shares issued 330 - - (82) - 248
Dividends to shareholders - - - - (7,512) (7,512)
Balance at 30 June 2012 1,175 - (1,783) 276 29,565 29,233
Balance at 1 July 2010 835 (98) (1,306) 544 24,527 24,502
- - - -
Profit for the year 7,465 7,465
Other comprehensive
income for the year
(net of tax) - 245 (602) - - (357)
Total comprehensive
income for the year - 245 (602) - 7,465 7,108
Lapsed employee options - - - (186) 186 -
- - - -
Expensed employee options (89) (89)
Shares issued 10 - - (3) - 7
Dividends to shareholders - - - - (4,171) (4,171)
Balance at 30 June 2011 845 147 (1,908) 266 28,007 27,357
----- End of picture text -----

The consolidated statement of changes in equity is to be read in conjunction with the notes to the financial statements set out on pages 43 to 73.

The consolidated statement of financial position is to be read in conjunction with the notes to the financial statements set out on pages 43 to 73.

40 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 41

Notes to the Financial Statements | page 43 – 73

Consolidated statement of cash flows

For the year ended 30 June 2012

==> picture [484 x 404] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD Notes 2012 2011
Cash flows from operating activities
Cash receipts from customers 45,565 43,875
Cash paid to suppliers and employees (29,409) (28,536)
Cash generated from operations 16,156 15,339
Income taxes paid (1,510) (1,485)
Net cash provided by operating activities 23 14,646 13,854
Cash flows from investing activities
Payments for capitalised development (6,730) (5,655)
Payments for property, plant and equipment (518) (397)
Payments for intangible assets (221) (243)
Interest received 509 381
Net cash used in investing activities (6,960) (5,914)
Cash flows from financing activities
Proceeds from issuing of shares 248 7
Payment of dividend 19 (7,512) (4,171)
Net cash used in financing activities (7,264) (4,164)
Net increase in cash and cash equivalents 422 3,776
Cash and cash equivalents at 1 July 11,635 8,396
Effects of exchange rate changes on cash (19) (537)
Cash and cash equivalents at 30 June 8 12,038 11,635
----- End of picture text -----

Notes to the Financial Statements

For the year ended 30 June 2012

Note 1: Significant accounting policies

The company is of a kind referred to in ASIC Class Order (CO) 98/100 dated 10 July 1998 (updated by CO 05/641 effective 28 July 2005 and CO 06/51 effective 31 January 2006) and in accordance with that Class Order, amounts in the financial report and Directors’ Report have been rounded off to the nearest thousand dollars, unless otherwise stated.

Integrated Research Limited (the “Company”) is a company domiciled in Australia. The financial report of the Company for the year ended 30 June 2012 comprises the Company and its subsidiaries (together referred to as the “consolidated entity”).

The preparation of financial statements in conformity with Australian Accounting Standards requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. These accounting policies have been consistently applied by each entity in the consolidated entity.

The financial report was authorised for issue by the directors on 21 August 2012.

a) Statement of Compliance

The financial report is a general purpose financial report which has been prepared in accordance with Australian Accounting Standards, and Interpretations and the Corporations Act 2001. Accounting Standards include Australian Equivalent to International Financial Reporting Standards (“AIFRS”). Compliance with AIFRS ensures the financial statements of the consolidated entity also comply with International Financial Reporting Standards and interpretations adopted by the International Accounting Standards Board.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

b) Basis of Preparation

The financial statements are presented in Australian dollars and are prepared on the historical cost basis, with the exception of cash flow hedges, which are at fair value.

The consolidated statement of cash flows is to be read in conjunction with the notes to the financial statements set out on pages 43 to 73.

42 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 43

Notes to the Financial Statements | page 43 – 73

Note 1: Significant accounting policies (cont.)

Standards and Interpretations issued not yet effective

At the date of authorisation of the financial report, a number of Standards and Interpretations were in issue but not yet effective.

Initial application of the following Standards is not expected to materially affect any of the amounts recognised in the financial statements, but may change the disclosures presently made in relation to the consolidated entity’s financial statements:

Standard/Interpretaton	Efectve for annual reportng periods beginning on or afer	Expected to be initally applied in the fnancial year ending
AASB 9_‘Financial Instruments’, AASB 2009-11 and AASB 2010-7_
‘Amendments to Australian Accountng Standards arising from
AASB 9’	1 January 2013	30 June 2014
AASB 2010-8_‘Amendments to Australian Accountng Standards –_
Deferred Tax: Recovery of Underlying Assets’	1 January 2012	30 June 2013
AASB 10_‘Consolidated Financial Statements’_	1 January 2013	30 June 2014
AASB 12_‘Disclosure of Interests in Other Enttes’_	1 January 2013	30 June 2014
AASB 13_‘Fair Value Measurement’ and AASB 2011-8_
‘Amendments to Australian Accountng Standards arising from
AASB 13’	1 January 2013	30 June 2014
AASB 119_‘Employee Benefts’(2011) and AASB 2011-10_ ‘Amendments to Australian Accountng Standards arising from
AASB 119 (2011)’	1 January 2013	30 June 2014
AASB 127_‘Separate Financial Statements’ (2011)_	1 January 2013	30 June 2014
AASB 2011-9_‘Amendments to Australian Accountng Standards – _Presentaton of Items of Other Comprehensive Income’	1 July 2012	30 June 2013
AASB 2012-2_‘Amendments to Australian Accountng Standards – _Disclosures – Ofsetng Financial Assets and Financial Liabilites’	1 January 2013	30 June 2014
AASB 2012-3_‘Amendments to Australian Accountng Standards – _Disclosures – Ofsetng Financial Assets and Financial Liabilites’	1 January 2014	30 June 2015
AASB 2012-5_‘Amendments to Australian Accountng Standards_
arising from Annual Improvements 2009-2011 Cycle’	1 January 2013	30 June 2014
At the date of authorisaton of the fnancial statements, the following IASBs were also in although Australian equivalent Standards have not yet been issued:		issue but not efectve,
Mandatory Efectve Date of IFRS 9 and Transiton Disclosures (Amendments to IFRS 9 and IFRS 7)	1 January 2015	30 June 2016
Consolidated Financial Statements, Joint Arrangements and Disclosure of Interests in Other Enttes: Transiton Guidance (amendments to IFRS 10, IFRS 11 and IFRS 12)	1 January 2013	30 June 2014

Note 1: Significant accounting policies (cont.)

The accounting policies set out below have been applied consistently to all periods presented in the consolidated financial statements.

c) Basis of consolidation

Subsidiaries are entities controlled by the company. Control exists when the company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. In assessing control, potential voting rights that presently are exercisable or convertible are taken into account. The financial statements of subsidiaries are included in the consolidated financial report from the date that control commences until the date that control ceases.

Intragroup balances and any gains and losses or income and expenses arising from intragroup transactions, are eliminated in preparing the consolidated financial statements.

d) Foreign currency

In preparing the financial statements of the individual entities transactions in foreign currencies are translated at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the year end date are translated to Australian dollars at the foreign exchange rate ruling at that date. Foreign exchange differences arising on translation are recognised in profit or loss. Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies that are stated at fair value are translated to Australian dollars at foreign exchange rates ruling at the dates the fair value was determined.

On consolidation, the assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on consolidation are translated to Australian dollars at foreign exchange rates ruling at the year end date. The revenues and expenses of foreign operations, are translated to Australian dollars at rates approximating the foreign exchange rates ruling at the dates of the transactions. Foreign exchange differences arising on retranslation are recognised directly in other comprehensive income and accumulated in the translation reserve.

e) Derivative financial instruments

The consolidated entity uses derivative financial instruments to hedge its exposure to foreign exchange risks arising from operational activities. In accordance with its treasury policy, the consolidated entity does not hold or issue derivative financial instruments for trading purposes. However, derivatives that do not qualify for hedge accounting are accounted for as trading instruments.

Derivative financial instruments are recognised initially at cost. Subsequent to initial recognition, derivative financial instruments are stated at fair value. The gain or loss on remeasurement to fair value is recognised immediately in profit or loss. However, where derivatives qualify for hedge accounting, recognition of any resultant gain or loss depends on the nature of the item being hedged.

The fair value of forward exchange contracts is their quoted market price at the year end date, being the present value of the quoted forward price.

f) Hedging

On entering into a hedging relationship, the consolidated entity normally designates and documents the hedge relationship and risk management objective and strategy for undertaking the hedge. The documentation includes identification of the hedging instrument, the hedged item or transaction, the nature of the risk being hedged and how the entity will assess the hedging instrument’s effectiveness in offsetting the exposure to changes in the item’s fair value or cash flows attributable to the hedged risk. Such hedges are expected to be highly effective in offsetting changes in fair value or cash flows and are assessed on an ongoing basis to determine that they actually have been highly effective throughout the financial reporting periods for which they are designated.

For cash flow hedges, the associated cumulative gain or loss is removed from equity and recognised in profit or loss in the same period or periods during which the hedged forecast transaction affects profit or loss. The ineffective part of any gain or loss is recognised immediately in the profit or loss.

44 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 45

Notes to the Financial Statements | page 43 – 73

Note 1: Significant accounting policies (cont.)

g) Property, plant and equipment

Items of property, plant and equipment are stated at cost or deemed cost less accumulated depreciation and impairment losses (see accounting policy (k)). The cost of acquired assets includes (i) the initial estimate at the time of installation and during the period of use, when relevant, of the costs of dismantling and removing the items and restoring the site on which they are located, and (ii) changes in the measurement of existing liabilities recognised for these costs resulting from changes in the timing or outflow of resources required to settle the obligation or from changes in the discount rate.

Where parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items of property, plant and equipment.

Depreciation is provided on property, plant and equipment. Depreciation is calculated on a straight line basis so as to write off the net cost of each asset over its expected useful life to its estimated residual value. Leasehold improvements are depreciated over the period of the lease or estimated useful life, whichever is the shorter, using the straight line method. The estimated useful lives, residual values and depreciation method are reviewed annually, with the effect of any changes recognised on a prospective basis.

The following useful lives are used in the calculation of depreciation:

Leasehold improvements 6 to 10 years Plant and equipment 4 to 8 years

h) Intangible Assets

Research and development Expenditure on research activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, is recognised in profit or loss as incurred.

Expenditure on development activities, whereby research findings are applied to a plan or design for the production of new or substantially improved products and processes, is capitalised if the product or process is technically and commercially feasible and the consolidated entity has sufficient resources to complete development.

The expenditure capitalised includes the cost of materials, direct labour and an appropriate proportion of overheads. Other development expenditure is recognised in profit or loss as an expense as incurred. Capitalised development expenditure is stated at cost less accumulated amortisation and impairment losses (see accounting policy (k)).

Amortisation is charged to profit or loss on a straightline basis over the estimated useful life, but no more than three years.

Intellectual property

Intellectual property acquired from third parties is amortised over its estimated useful life, but no more than three years.

Computer software

Computer software is stated at cost and depreciated on a straight-line basis over a 2½ to 3 year period.

i) Trade and other receivables

Trade and other receivables are stated at their amortised cost less impairment losses. The carrying amount of uncollectible trade receivables is reduced by an impairment loss through the use of an allowance account.

Allowance for returns is offset against trade receivables for estimated warranty claims based upon historical experience.

j) Cash and cash equivalents

Cash and cash equivalents comprises cash balances and call deposits with an original maturity of three months or less. Bank overdrafts that are repayable on demand and form an integral part of the consolidated entity’s cash management are included as a component of cash and cash equivalents for the purpose of the statement of cash flows.

Note 1: Significant accounting policies (cont.)

k) Impairment

The carrying amounts of the consolidated entity’s assets are reviewed at each reporting date to determine whether there is any indication of impairment. If any such indication exists, the asset’s recoverable amount is estimated.

For intangible assets that are not yet available for use, the recoverable amount is estimated at each year end date.

An impairment loss is recognised whenever the carrying amount of an asset or its cash generating unit exceeds its recoverable amount. Impairment losses are recognised in profit or loss unless the asset has previously been revalued, in which case the impairment loss is recognised as a reversal to the extent of that previous revaluation with any excess recognised through profit or loss.

The recoverable amount of other assets is the greater of their fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit to which the asset belongs.

l) Employee benefits

Superannuation

Obligations for contributions to defined contribution pension plans are recognised as an expense in profit or loss as incurred. There are no defined benefit plans in operation.

Long-term service benefits

The consolidated entity’s net obligation in respect of long-term service benefits, other than pension plans, is the amount of future benefit that employees have earned in return for their service in the current and prior periods. The obligation is calculated using expected future increases in wage and salary rates including related on-costs and expected settlement dates, and is discounted using the rates attached to the Commonwealth Government bonds at the year end date which have maturity dates approximating to the terms of the consolidated entity’s obligations.

Share-based payment transactions

The share option and performance rights programmes allows the consolidated entity’s employees to acquire shares of the Company. The fair value of options and performance rights granted are recognised as an employee expense with a corresponding increase in equity. The fair value is measured at grant date and spread over the period during which the employees become unconditionally entitled to the options or the performance rights. The fair value of the instrument granted is measured using a binomial option pricing model, taking into account the terms and conditions upon which the options were granted. The amount recognised as an expense is adjusted to reflect the actual number of share options or performance rights that are expected to vest.

Wages, salaries, annual leave, and non-monetary benefits Liabilities for employee benefits for wages, salaries and annual leave represent present obligations resulting from employees’ services provided to the year end date, calculated at undiscounted amounts based on remuneration wage and salary rates that the consolidated entity expects to pay as at the year end date.

m) Provisions

A provision is recognised in the statement of financial position when the consolidated entity has a present legal or constructive obligation as a result of a past event, and it is probable that an outflow of economic benefits will be required to settle the obligation. Provisions are determined by discounting the expected future cash flows at a pre-tax rate that reflects current market assessments of the time value of money and, where appropriate, the risks specific to the liability.

n) Trade and other payables Trade and other payables are stated at their amortised cost.

46 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 47

Notes to the Financial Statements | page 43 – 73

Note 1: Significant accounting policies (cont.)

o) Revenue

The consolidated entity allocates revenue to each element in software arrangements involving multiple elements based on the relative fair value of each element. The typical elements in the multiple element arrangement are licence and maintenance fees. The company’s determination of fair value is generally based on the price charged when the same element is sold separately.

Revenue from the sale of licences, where the consolidated entity has no post delivery obligations to perform is recognised in profit or loss at the date of delivery of the licence key.

Revenue from maintenance contracts is recognised rateably over the term of the service agreement, which is typically one year. Maintenance contracts are typically priced based on a percentage of licence fees and have a one year term. Services provided to customers under maintenance contracts include technical support and supply of software updates.

Revenue from multiple element software arrangements, where the fair value of an undelivered element cannot be reliably measured are recognised over the period the undelivered services are provided.

Revenue from consulting services is recognised over the period the services are provided.

No revenue is recognised if there are significant uncertainties regarding the recovery of the consideration due, the costs incurred or to be incurred cannot be measured reliably, there is a risk of return of goods or there is continuing management involvement with the goods.

p) Expenses

Operating lease payments

Payments made under operating leases are recognised in profit or loss on a straight-line basis over the term of the lease. Lease incentives received are recognised in profit or loss as an integral part of the total lease expense and spread over the lease term.

q) Income tax

Income tax on the profit or loss for the periods presented comprises current and deferred tax. Income tax is recognised in profit or loss except to the extent that it relates to items recognised directly in equity, in which case it is recognised in equity.

Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at the year end date, and any adjustment to tax payable in respect of previous years.

Deferred tax is recognised on temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. The amount of deferred tax provided is based on the expected manner of realisation or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the year end date.

A deferred tax asset is recognised only to the extent that it is probable that future taxable profits will be available against which the asset can be utilised. Deferred tax assets are reduced to the extent that it is no longer probable that the related tax benefit will be realised.

Additional dividend franking deficit tax that arises from the distribution of dividends are recognised at the same time as the liability to pay the related dividend.

r) Goods and Services Tax

Revenue, expenses and assets are recognised net of the amount of goods and services tax (GST), or similar taxes, except where the amount of GST incurred is not recoverable from the taxation authority. In these circumstances, the GST is recognised as part of the cost of acquisition of the asset or as part of the expense.

Receivables and payables are stated with the amount of GST included. The net amount of GST recoverable or payable is included as a current asset or liability in the statement of financial position.

Cash flows are included in the statement of cash flows on a gross basis. The GST components of cash flows arising from investing and financing activities, which are recoverable or payable are classified as operating cash flows.

Note 1: Significant accounting policies (cont.)

s) Significant accounting judgements, estimates and assumptions

The carrying amounts of certain assets and liabilities are often determined based on estimates and assumptions of future events. The key estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of certain assets and liabilities within the next annual reporting period are:

Intangible assets

An intangible asset arising from development expenditure on an internal project is recognised only when the consolidated entity can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or sell the asset, how the asset will generate future economic benefits, the availability of resources to complete the development and the ability to measure reliably the expenditure attributable to the intangible asset during its development. Following the initial recognition of the development expenditure, the cost model is applied requiring the asset to be carried at cost less any accumulated amortisation and accumulated impairment losses. Any expenditure so capitalised is amortised over the period of expected benefits from the related project commencing from the commercial release of the project. The carrying value of an intangible asset arising from development expenditure is tested for impairment annually when the asset is not yet available for use or more frequently when an indication of impairment arises during the reporting period.

Share based payment transactions

The consolidated entity measures the cost of equitysettled transactions with employees by reference to the fair value of the equity instruments at the date at which they are granted. The fair value is determined by using a binomial option pricing model and applying management determined probability factors relating to non-market vesting conditions.

Receivables

The consolidated entity assesses impairment of receivables based upon assessment of objective evidence for significant receivables and by placing non significant receivables in portfolios of similar risk profiles, based on objective evidence from historical experience adjusted for any effects of conditions existing at each reporting date. This assessment includes judgements and estimates of future outcomes the actual results of which may differ from the estimates at the reporting date.

Financing income

Financing income comprises interest receivable on funds invested.

48 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 49

Notes to the Financial Statements | page 43 – 73

Note 2. Segment reporting

The information reported to the CODM (being the Chief Executive Officer) for the purposes of resource allocation and assessment of performance is focused on geographical performance. The principal geographical regions are The Americas – operating from the United States with responsibility for the countries in North, Central and South America, Europe – operating from the United Kingdom with responsibility for the countries in Europe, Asia Pacific – operating from Australia with responsibility for the countries in the rest of the world and Corporate Australia – includes revenue and expenses for research and development and corporate head office functions of the company.

Inter-segment pricing is determined on an arm’s length basis.

Segment profit represents the profit earned by each segment without allocation of investment revenue and income tax expense. This is the measure reported to the chief operating decision maker for the purposes of resource allocation and assessment of segment performance.

Information regarding these segments is presented below. The accounting policies of the reportable segments are the same as the Group’s accounting policies.

==> picture [484 x 347] intentionally omitted <==

----- Start of picture text -----

Americas Europe Asia Pacific Corporate Eliminations Consolidated
Australia
In thousands of AUD 2012 2011 2012 2011 2012 2011 2012 2011 2012 2011 2012 2011
Sales to customers
outside the
consolidated entity 31,890 26,706 7,183 7,099 8,668 8,858 867 1,929 - - 48,608 44,592
- - - - - - -
Inter-segment sales 26,594 23,890 (26,594) (23,890)
Total segment
revenue 31,890 26,706 7,183 7,099 8,668 8,858 27,461 25,819 (26,594) (23,890) 48,608 44,592
Total revenue 48,608 44,592
Segment results 784 777 175 168 244 225 9,856 8,143 - - 11,059 9,313
Results from
operating activities 11,059 9,313
Financing income 509 381
Income tax expense (2,533) (2,229)
Profit for the year 9,035 7,465
Capital additions 203 61 32 37 - - 504 542 - - 739 640
Depreciation
and amortisation
expenditure 67 63 20 20 - - 7,402 6,478 - - 7,489 6,561
Non-current assets 1,048 822 108 93 - - 17,478 17,926 (54) (54) 18,580 18,787
----- End of picture text -----*

==> picture [487 x 115] intentionally omitted <==

----- Start of picture text -----

||||||||
|---|---|---|---|---|---|---|
| Corporate Australia|
|Americas (USD)|Europe (UK Sterling)|includes both the research|
|and development and|
|In thousands of local currency||2012|2011|2012|2011|corporate head office functions|
|of the Company.|
|Sales to customers outside the consolidated entity|33,137|26,489|4,687|4,416| Excludes internal development|
|costs capitalised but includes|
|-|-|-|-|
|Inter-segment sales|third party assets acquired.|
|*** Segment results|
|Total segment revenue|33,137|26,489|4,687|4,416|represented in local currencies|
|as reviewed by the Chief|
|Segment results|825|662|114|110|Operating Decision Maker|

----- End of picture text -----

Note 3. Finance income

==> picture [483 x 68] intentionally omitted <==

----- Start of picture text -----

||||
|---|---|---|
|Consolidated|
|In thousands of AUD|2012|2011|
|Interest income|509|381|
|509|381|

----- End of picture text -----

Note 4. Expenses

Total expenses include:

==> picture [483 x 188] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD 2012 2011
Employee benefits expense:
Defined contribution plans 1,382 1,150
Equity settled share-based payments 127 (89)
Other employee benefits 25,316 23,350
26,825 24,411
Depreciation and amortisation 7,489 6,561
Bad and doubtful debt expense 572 227
Operating lease rental expenses 1,207 1,258
----- End of picture text -----

==> picture [537 x 443] intentionally omitted <==

----- Start of picture text -----

Other employee benefits 25,316 23,350
26,825 24,411
Depreciation and amortisation 7,489 6,561
Bad and doubtful debt expense 572 227
Operating lease rental expenses 1,207 1,258
Note 5. Auditors’ remuneration
2012 and 2011 – Deloitte Touche Tohmatsu
Consolidated
In AUD 2012 2011
Remuneration for audit and review of the financial reports of the Company
or any entity in the consolidated entity:
Audit and review of financial reports:
Auditors of the company 168,000 163,760
Other auditors 15,530 15,308
Remuneration for other services by the auditors of the Company or any
entity in the consolidated entity:
Taxation services:
Auditors of the company 16,800 15,750
Other auditors 1,932 1,531
Other services:
Other auditors 3,523 -
Directors’ Report
Remuneration Report
Statement
Corporate Governance
Financial Statements
Audit ReportIndependent
----- End of picture text -----

50 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 51

Notes to the Financial Statements | page 43 – 73

Note 6. Income tax expense

Recognised in profit for the year

==> picture [484 x 169] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD Note 2012 2011
Current tax expense:
Current year 2,326 2,752
Prior year adjustments (24) (69)
2,302 2,683
Deferred tax expense:
Origination and reversal of temporary differences 13 231 (454)
Total income tax expense in profit and loss 2,533 2,229
----- End of picture text -----

Numerical reconciliation between income tax expense and profit before tax

==> picture [484 x 222] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD 2012 2011
Profit before tax 11,568 9,694
Income tax using the domestic corporate tax rate of 30% 3,470 2,908
Increase in income tax expense due to:
Non-deductible expenses 79 11
Effect of tax rates in foreign jurisdictions 105 69
Decrease in income tax expense due to:
R&D tax incentive (1,097) (751)
Other - 61
Prior year adjustments (24) (69)
Income tax expense 2,533 2,229
----- End of picture text -----

Note 7. Earnings per share

The calculation of basic and diluted earnings per share at 30 June 2012 was based on the profit attributable to ordinary shareholders of $9,035,000 (2011: $7,465,000); a weighted number of ordinary shares outstanding during the year ended 30 June 2012 of 166,977,446 (2011: 166,837,850); and a weighted number of ordinary shares (diluted) outstanding during the year ended 30 June 2012 of 168,086,211 (2011: 167,055,263), calculated as follows:

==> picture [484 x 50] intentionally omitted <==

----- Start of picture text -----

||||
|---|---|---|
|Consolidated|
|In thousands of AUD|2012|2011|
|Profit for the year|9,035|7,465|

----- End of picture text -----

Note 7. Earnings per share (cont.)

Weighted average number of shares used as the denominator

==> picture [483 x 162] intentionally omitted <==

----- Start of picture text -----

Consolidated
(Number) 2012 2011
Number for basic earnings per share:
Ordinary shares 166,977,446 166,837,850
Effect of employee share plans on issue 1,108,765 217,413
Number for diluted earnings per share 168,086,211 167,055,263
Basic earnings per share (AUD cents) 5.41¢ 4.47¢
Diluted earnings per share (AUD cents) 5.38¢ 4.47¢
----- End of picture text -----

Note 8. Cash and cash equivalents

==> picture [483 x 50] intentionally omitted <==

----- Start of picture text -----

||||
|---|---|---|
|Consolidated|
|In thousands of AUD|2012|2011|
|Cash at bank and on hand|12,038|11,635|

----- End of picture text -----

Note 9. Trade and other receivables

Current

==> picture [483 x 138] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD 2012 2011
Trade debtors 21,878 14,620
Less: Allowance for doubtful debts (516) (244)
Less: Allowance for returns (721) (418)
20,641 13,958
GST receivable 84 100
20,725 14,058
----- End of picture text -----

Non-current

==> picture [483 x 50] intentionally omitted <==

----- Start of picture text -----

||||
|---|---|---|
|Consolidated|
|In thousands of AUD|2012|2011|
|Trade debtors|656|1,018|

----- End of picture text -----

52 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 53

Notes to the Financial Statements | page 43 – 73

Note 9. Trade and other receivables (cont.)

The credit period on sales ranges from 30 to 90 days although in limited circumstances extended payment terms have been offered. No interest is charged on trade debtors.

Ageing of past due but not impaired:

==> picture [484 x 50] intentionally omitted <==

----- Start of picture text -----

||||
|---|---|---|
|Consolidated|
|In thousands of AUD|2012|2011|
|Past due 90 days|3,772|2,637|

----- End of picture text -----

The movement in the allowance for doubtful debts in respect of trade receivables is detailed below:

==> picture [484 x 103] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD 2012 2011
Balance at beginning of year 244 470
Amounts written off during the year (300) (453)
Increase in provision 572 227
Balance end of year 516 244
----- End of picture text -----

The consolidated entity has used the following criteria to assess the allowance loss for trade receivables and as a result is unable to specifically allocate the allowance to the ageing categories shown above:

Æ historical bad debt experience;
Æ the general economic conditions;
Æ an individual account by account specific risk assessment based on past credit history; and
Æ any prior knowledge of debtor insolvency or other credit risk.

Included in the consolidated entity’s trade receivable balance are debtors with a carrying amount of $2,535,000 (2011: $1,975,000) which are 90 days past due at the reporting date which the consolidated entity has not provided for as there has been no significant change in credit quality and the consolidated entity believes that the amounts are still considered recoverable. The consolidated entity does not hold any collateral over these balances.

Note 11. Other financial assets

==> picture [483 x 50] intentionally omitted <==

----- Start of picture text -----

||||
|---|---|---|
|Consolidated|
|In thousands of AUD|2012|2011|
|Deposits|1,802|1,800|

----- End of picture text -----

Deposits are term deposits which are held to secure a bank guarantee on leased premises and a foreign exchange facility. The carrying amount of other financial assets is a reasonable approximation of their fair value.

Note 12. Property, plant and equipment

==> picture [483 x 264] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD 2012 2011
Plant and Equipment
At cost 4,321 3,844
Accumulated depreciation (3,458) (3,052)
863 792
Leasehold Improvements
At cost 2,068 1,993
Accumulated depreciation (1,111) (910)
957 1,083
Total property, plant and equipment
At cost 6,389 5,837
Accumulated depreciation (4,569) (3,962)
Total written down amount 1,820 1,875
----- End of picture text -----

Note 10. Other current assets

==> picture [484 x 85] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD 2012 2011
Other prepayments 676 463
Fair value of hedge asset – forward foreign exchange contracts 277 666
953 1,129
----- End of picture text -----

54 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 55

Notes to the Financial Statements | page 43 – 73

Note 12. Property, plant and equipment (cont.)

Note 13. Deferred tax assets and liabilities (cont.)

Movement in temporary differences during the year:

==> picture [484 x 257] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD 2012 2011
Plant and Equipment
Carrying amount at start of year 792 788
Additions 445 397
Effects of foreign currency exchange 6 (36)
Depreciation expense (380) (357)
Carrying amount at end of year 863 792
Leasehold Improvements
Carrying amount at start of year 1,083 1,276
Additions 73 -
Effects of foreign currency exchange (1) 6
Depreciation expense (198) (199)
Carrying amount at end of year 957 1,083
----- End of picture text -----

Note 13. Deferred tax assets and liabilities

Deferred tax assets and liabilities are attributable to the following:

==> picture [484 x 228] intentionally omitted <==

----- Start of picture text -----

Consolidated Assets Liabilities Net
In thousands of AUD 2012 2011 2012 2011 2012 2011
Property, plant and equipment - - 50 - (50) -
- -
Intangible assets 4,063 4,021 (4,063) (4,021)
Trade and other payables 468 567 - - 468 567
Employee benefits 772 596 - - 772 596
Provisions 364 243 - - 364 243
- - - - - -
Other current liabilities
Unrealised foreign exchange gain - - 41 - (41) -
Unrealised foreign exchange loss - 296 - - - 296
Deferred tax assets/liabilities 1,604 1,702 4,154 4,021 (2,550) (2,319)
- -
Set off of deferred tax asset (1,151) (1,416) (1,151) (1,416)
Net deferred tax assets/liabilities 453 286 3,003 2,605 (2,550) (2,319)
----- End of picture text -----

==> picture [483 x 185] intentionally omitted <==

----- Start of picture text -----

For year ended 30 June 2012 Consolidated
Balance Recognised Recognised Balance
In thousands of AUD 1 July 11 in income in equity 30 June 12
- -
Property, plant and equipment (50) (50)
-
Intangible assets (4,021) (42) (4,063)
Trade and other payables 567 (99) - 468
Employee benefits 596 176 - 772
Provisions 243 121 - 364
- -
Unrealised foreign exchange gain (41) (41)
Unrealised foreign exchange loss 296 (296) - -
-
(2,319) (231) (2,550)
----- End of picture text -----

==> picture [483 x 46] intentionally omitted <==

----- Start of picture text -----

For year ended 30 June 2011 Consolidated
Balance Recognised Recognised Balance
In thousands of AUD 1 July 10 in income in equity 30 June 11
----- End of picture text -----

==> picture [483 x 138] intentionally omitted <==

----- Start of picture text -----

||||||
|---|---|---|---|---|
|Property, plant and equipment|28|(28)|-|-|
|Intangible assets|(4,185)|164|-|(4,021)|
|Trade and other payables|339|228|-|567|
|Employee benefits|510|86|-|596|
|Provisions|670|(427)|-|243|
|Unrealised foreign exchange gain|(162)|162|-|-|
|Unrealised foreign exchange loss|69|269|(42)|296|
|(2,731)|454|(42)|(2,319)|

----- End of picture text -----

Note 14. Intangible assets

The amortisation is recognised in the following line item in the statement of comprehensive income:

==> picture [483 x 68] intentionally omitted <==

----- Start of picture text -----

||||
|---|---|---|
|Consolidated|
|In thousands of AUD|2012|2011|
|Research and development expenses|6,911|6,005|
|6,911|6,005|

----- End of picture text -----

56 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 57

Notes to the Financial Statements | page 43 – 73

Note 14. Intangible assets (cont.)

==> picture [484 x 272] intentionally omitted <==

----- Start of picture text -----

Cost Consolidated
Software Third party Total
In thousands of AUD development software
Balance at 1 July 2010 28,193 1,551 29,744
Fully amortised & offset (12,490) (205) (12,695)
-
Effects of foreign currency exchange (44) (44)
-
Internally developed 5,655 5,655
Acquired 61 181 242
Balance at 30 June 2011 21,419 1,483 22,902
Balance at 1 July 2011 21,419 1,483 22,902
-
Fully amortised & offset (7,242) (7,242)
Effects of foreign currency exchange - 3 3
-
Internally developed 6,730 6,730
Acquired 57 164 221
Balance at 30 June 2012 20,964 1,650 22,614
----- End of picture text -----

Note 14. Intangible assets (cont.)

==> picture [483 x 80] intentionally omitted <==

----- Start of picture text -----

Carrying amounts Consolidated
Software Patents and Third party Total
In thousands of AUD development trademarks software
Balance at 30 June 2011 13,404 - 404 13,808
Balance at 30 June 2012 13,542 - 307 13,849
----- End of picture text -----

Note 15. Trade and other payables

==> picture [483 x 68] intentionally omitted <==

----- Start of picture text -----

||||
|---|---|---|
|Consolidated|
|In thousands of AUD|2012|2011|
|Trade and other creditors|4,285|3,365|
|4,285|3,365|

----- End of picture text -----

The average credit period on trade and other payables is 30 days.

Note 16. Employee benefits

Current

==> picture [484 x 240] intentionally omitted <==

----- Start of picture text -----

Amortisation Consolidated
Software Third party Total
In thousands of AUD development software
Balance at 1 July 2010 14,684 1,103 15,787
Fully amortised & offset (12,490) (205) (12,695)
-
Effects of foreign currency exchange (3) (3)
Amortisation for year 5,821 184 6,005
Balance at 30 June 2011 8,015 1,079 9,094
Balance at 1 July 2011 8,015 1,079 9,094
-
Fully amortised & offset (7,242) (7,242)
- 2 2
Effects of foreign currency exchange
Amortisation for year 6,649 262 6,911
Balance at 30 June 2012 7,422 1,343 8,765
----- End of picture text -----

==> picture [483 x 85] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD 2012 2011
Liability for annual leave 1,314 1,084
Liability for long service leave 465 444
1,779 1,528
----- End of picture text -----

Non-current

==> picture [483 x 50] intentionally omitted <==

----- Start of picture text -----

||||
|---|---|---|
|Consolidated|
|In thousands of AUD|2012|2011|
|Liability for long service leave|242|149|

----- End of picture text -----

Pension plans

Employees of the consolidated entity accumulate pension benefits through statutory contributions by the entities in the consolidated entity as required by the laws of the jurisdictions in which they operate, supplemented by individual contributions.

58 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 59

Notes to the Financial Statements | page 43 – 73

Note 16. Employee benefits (cont.)

Share based payments

Performance Rights

On 21 November 2011, the consolidated entity established the Integrated Research Performance Rights and Options Plan (IRPROP). The plan enables the Company to offer performance rights to eligible employees to obtain shares in Integrated Research at no cost contingent upon performance conditions being met. The performance conditions for non-executive employees includes a service period and performance components. The performance conditions for executives includes a service period and profit after tax hurdles. The performance rights are automatically exercised into shares upon the performance conditions being met. The following performance rights were granted during the period:

Note 16. Employee benefits (cont.)

Share Options

On 4 October 2000, the consolidated entity established a share option programme that entitles employees to purchase shares in the entity. In accordance with this programme, options are exercisable at the market price of the shares at the date of grant.

The terms and conditions of the grants made and number outstanding at 30 June 2012 are as follows:

Æ All options vest at the rate of 25% per annum, starting on the first anniversary of the grant date
Æ The contractual life of each option is five years from the grant date
Æ Exercises are settled by physical delivery of shares

Grant Date	Type	Number of Rights	Vestng Date	Expiry date
December 2011	Non-Executve	887,500	15 Oct 2014	15 Nov 2014
December 2011	Executve	665,000	31 Aug 2014	30 Sep 2014

The fair value of the performance rights including assumptions used are as follows:

Grant date	Executve	Non-Executve
	30 Dec 11	30 Dec 11
Fair value at measurement date	$0.38	$0.38
Share price	$0.47	$0.47
Exercise price	nil	nil
Expected volatlity	51%	51%
Contractual life (expressed in days)	1,005	1,051
Expected dividends	7.5%	7.5%
Risk-free interest rate (based on 3 year treasury bonds)	3.1%	3.1%

The fair values of services received in return for performance rights granted to employees is measured by reference to the fair value of share options granted. The estimate of the fair value of the services received is measured based on a Binomial option-pricing model.

During the year ended 30 June 2012, the consolidated entity recognised an expense through profit of $83,000 related to the fair value of performance rights granted (2011: $nil).

The following table provides the movement in performance rights during the year:

==> picture [484 x 143] intentionally omitted <==

----- Start of picture text -----

Executive Non-Executive Executive Non-Executive
In thousands of performance rights 2012 2012 2011 2011
- - - -
Outstanding at the beginning of the year
- - -
Forfeited during the year (18)
- - - -
Exercised during the year
Granted during the year 665 888 - -
Outstanding at the end of the year 665 870 - -
- - - -
Exercisable at the end of the year (vested)
----- End of picture text -----

Æ Grants marked (*) include performance hurdles as conditions for vesting

==> picture [489 x 104] intentionally omitted <==

----- Start of picture text -----

Grant date Exercise Price Number of Grant date Exercise Price Number of
Instruments Instruments
Outstanding Outstanding
Sep 2007 () $0.42 1,000,000 Oct 2008 () $0.31 340,000
Apr 2008 () $0.38 350,000 May 2009 $0.28 755,000
Jul 2008 () $0.35 200,000
----- End of picture text -----

The number and weighted average exercise prices of share options is as follows:

Weighted Average exercise price	Number of optons Weighted Average exercise price Number of optons
In thousands of optons 2012	2012 2011 2011
Outstanding at the beginning of the year $0.37	3,872 $0.38 5,420
Forfeited during the year $0.42	(572) $0.42 (1,523)
Exercised during the year $0.38	(655) $0.28 (25)
Granted during the year -	- - -
Outstanding at the end of the year $0.36	2,645 $0.37 3,872
Exercisable at the end of the year (vested) $0.35	1,289 $0.38 1,429

The options outstanding at 30 June 2012 have a weighted average exercise price of $0.36 and a weighted average of contractual life of five years from inception.

During the year ended 30 June 2012, 654,500 options were exercised (2011: 25,000).

The fair values of services received in return for share options granted to employees is measured by reference to the fair value of share options granted. The estimate of the fair value of the services received is measured based on the Binomial option-pricing model. The contractual life of the option (five years) is used as an input into this formula. Expectations of early exercise are incorporated into the Binomial formula.

There were no options granted during the 2012 financial year (2011:nil).

During the year ended 30 June 2012, the consolidated entity recognised an expense through profit of $44,000 related to the fair value of options granted (2011: credit of $89,000).

60 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 61

Notes to the Financial Statements | page 43 – 73

Note 17. Provisions

Current

==> picture [484 x 68] intentionally omitted <==

----- Start of picture text -----

|||||
|---|---|---|---|
|Consolidated|
|In thousands of AUD|Note|2012|2011|
|Employee benefits|16|1,779|1,528|
|1,779|1,528|

----- End of picture text -----

Note 19. Capital and reserves

Share capital

==> picture [483 x 85] intentionally omitted <==

----- Start of picture text -----

Ordinary shares
In thousands of shares 2012 2011
On issue 1 July 166,852 166,827
Issued against employee options exercised 655 25
On issue 30 June 167,507 166,852
----- End of picture text -----

Non-current

==> picture [484 x 85] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD Note 2012 2011
Employee benefits 16 242 149
Lease make good 379 379
621 528
----- End of picture text -----

Note 18. Other liabilities

Current

==> picture [484 x 85] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD 2012 2011
Fair value of hedge liabilities - forward foreign exchange contracts 102 18
Deferred revenue 9,730 8,719
9,832 8,737
----- End of picture text -----

Effective 1 July 1998, the Company Law reform Act abolished the concept of par value shares and the concept of authorised capital. Accordingly, the company does not have authorised capital or par value in respect of its issued shares.

The holders of ordinary shares are entitled to receive dividends as declared from time to time and are entitled to one vote per share at meetings of the Company. All shares rank equally with regard to the Company’s residual assets.

Hedging reserve

The hedging reserve comprises the effective portion of the cumulative net change in the fair value of cash flow hedging instruments related to hedged transactions that have not yet occurred.

Translation reserve

The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations where their functional currency is different to the presentation currency of the consolidated entity, as well as from the translation of liabilities that hedge the consolidated entity’s net investment in a foreign subsidiary.

Employee benefit reserve

The employee benefit reserve arises on the grant of either share options or performance rights to employees under the Integrated Research Performance Rights and Option Plan (established November 2011) or the Employee Share Option Plan (established October 2000). Amounts are transferred out of the reserve and into share capital when the options or performance rights are exercised. Refer to Note 16 for further details.

Dividends

Dividends recognised in the current year by the company are:

Non-current

==> picture [484 x 50] intentionally omitted <==

----- Start of picture text -----

||||
|---|---|---|
|Consolidated|
|In thousands of AUD|2012|2011|
|Deferred revenue|2,053|540|

----- End of picture text -----

==> picture [483 x 182] intentionally omitted <==

----- Start of picture text -----

Cents per share Total amount Franked/ Date of
In thousands of AUD unfranked payment
2012
Final 2011 2.5 4,172 75% franked 16 Sep 2011
Interim 2012 2.0 3,340 40% franked 16 Mar 2012
Total amount 4.5 7,512
2011
Final 2010 1.0 1,668 45% franked 17 Sep 10
Interim 2011 1.5 2,503 50% franked 11 Mar 11
Total amount 2.5 4,171
----- End of picture text -----

62 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 63

Notes to the Financial Statements | page 43 – 73

Note 19. Capital and reserves (cont.)

After the end of the financial year, the following dividend was proposed by the directors. The financial effect of this dividend has not been brought to account in the financial statements for the year ended 30 June 2012 and will be recognised in subsequent financial statements:

Cents per share	Total amount	Franked/	Date of
In thousands of AUD		unfranked	payment
Final 2012 3.0	5,033	70% franked	14 Sep 12

The final dividend declared of 3.0 cents together with the interim dividend paid in March 2012 of 2.0 cents takes total dividends for the 2012 financial year to 5.0 cents.

Note 20. Financial instruments (cont.)

Market risk

The consolidated entity’s activities expose it primarily to the financial risks of changes in foreign currency exchange rates and cash flow interest rate risks. The consolidated entity enters into foreign exchange forward contracts to hedge the exchange rate risk arising from transactions not recorded in an entity’s functional currency.

Foreign currency risk management

The consolidated entity undertakes certain transactions denominated in foreign currencies, hence exposures to exchange rate fluctuations arise. Exchange rate exposures are managed within approved policy parameters utilising forward foreign exchange contracts.

The carrying amount of the consolidated entity’s foreign currency denominated monetary assets and monetary liabilities at the reporting date that are denominated in a currency that is different to the functional currency of the respective entities undertaking the transactions is as follows:

Franking account disclosure:

Company	Company
In thousands of AUD 2012	2011
Adjusted franking account balance 1,669	1,446
Impact on franking account balance of dividends not recognised (1,510)	(1,340)

Note 20. Financial instruments

Capital risk management

The consolidated entity manages its capital to ensure that controlled entities will be able to continue as a going concern while maximising the return to stakeholders through the optimisation of treasury management.

The capital structure of the consolidated entity consists of cash and cash equivalents and equity attributable to equity holders of the company, comprising issued capital, reserves, and retained earnings as disclosed in Notes 8 and 19 respectively.

Significant accounting policies

Details of the significant accounting policies and methods adopted, including the criteria for recognition, the basis of measurement and the basis on which income and expenses are recognised, in respect of each class of financial asset, financial liability and equity instrument are disclosed in Note 1 to the financial statements.

Financial risk management objectives

The Board of Directors has overall responsibility for the establishment and oversight of the consolidated entity’s financial management framework. The Board has an established Audit and Risk Committee, which is responsible for developing and monitoring the consolidated entity’s financial management policies. The Committee provides regular reports to the Board of Directors on its activities.

The Audit and Risk Committee oversees how Management monitors compliance with risk management policies and procedures and reviews the adequacy of the risk management framework in relation to the risks.

The main risks arising from the consolidated entity’s financial instruments are currency risk, credit risk, liquidity risk and cash flow interest rate risk.

The consolidated entity seeks to minimise the effects of these risks, where deemed appropriate, by using derivative financial instruments to hedge these risk exposures. The use of financial derivatives is governed by the consolidated entity’s policies on foreign exchange risk, credit risk, the use of financial derivatives and non-derivative financial instruments, and the investment of excess liquidity. The consolidated entity does not enter into or trade financial instruments, including derivative financial instruments, for speculative purposes.

	Consolidated
	Liabilites Assets
In thousands of AUD	2012 2011 2012 2011
US Dollar	- - 3,400 1,700
Euro	- - 2,507 1,611
UK Sterling	- - 9 9

Foreign currency sensitivity

At 30 June 2012, if the US Dollar, Euro and UK Sterling weakened against the Australian Dollar by the percentage shown, with all other variables held constant, net profit for the year would increase (decrease) by:

	Consolidated
	US Impact Euro Impact Sterling Impact
In thousands of AUD	2012 2011 2012 2011 2012 2011
Net proft	378 189 279 179 1 1
Retained earnings	378 189 279 179 1 1
Change in currency (i) – 10% decrease

(i) This has been based on the change in the exchange rate against the Australian Dollar in the financial years ended 30 June 2012 and 30 June 2011.

The sensitivity analysis has been based on the sensitivity rates used when reporting foreign currency risk internally to key management personnel and represents management’s assessment of the possible change in foreign exchange rates based on historical volatility.

In management’s opinion, the sensitivity analysis is not fully representative of the inherent foreign exchange risk as the year end exposure does not necessarily reflect the exposure during the course of the year. The consolidated entity includes certain subsidiaries whose functional currencies are different to the consolidated entity presentation currency. The main operating entities outside of Australia are based in the United States and the United Kingdom. As stated in the consolidated entity’s accounting policies per Note 1, on consolidation the assets and liabilities of these entities are translated into Australian dollars at exchange rates prevailing on the year end date. The income and expenses of these entities is translated at the average exchange rates for the year. Exchange differences arising are classified as equity and are transferred to a foreign exchange translation reserve. The consolidated entity’s future reported profits could therefore be impacted by changes in rates of exchange between the Australian Dollar and the United States Dollar and the Australian Dollar and the UK Sterling.

64 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 65

Notes to the Financial Statements | page 43 – 73

Note 20. Financial instruments (cont.)

Forward foreign exchange contracts

The consolidated entity is exposed to foreign currency risk on sales and purchases that are denominated in a currency other than the AUD. The currencies giving rise to this risk are primarily United States Dollar and UK Sterling.

The consolidated entity uses forward exchange contracts to hedge its foreign currency risk. The forward exchange contracts have maturities of less than two years after the year end date.

The consolidated entity classifies its forward exchange contracts hedging forecasted transactions as cash flow hedges and measures them at fair value. The following table details the forward foreign currency contracts outstanding as at reporting date:

==> picture [484 x 363] intentionally omitted <==

----- Start of picture text -----

Outstanding contracts Average Exchange Rate Foreign Currency Contract Value Fair Value
2012 2011 2012 2011 2012 2011 2012 2011
FC’000 FC’000 A$’000 A$’000 A$’000 A$’000
Consolidated
Sell US Dollar
Less than 3 months 1.01 0.89 3,500 2,650 3,468 2,981 8 487
3 to 6 months 1.01 0.99 2,250 1,600 2,228 1,619 (11) 98
6 to 9 months 1.01 1.02 3,250 1,100 3,205 1,082 (51) 26
9 to 12 months - 1.01 - 1,500 - 1,481 - 25
Sell UK Sterling
Less than 3 months - - - - - - - -
Sell Euros
Less than 3 months 0.71 0.71 1,100 300 1,540 420 168 12
3 to 6 months 0.71 0.73 300 300 424 409 47 (3)
6 to 9 months 0.76 0.72 300 400 395 559 14 5
9 to 12 months - 0.72 - 200 - 277 - (2)
175 648
----- End of picture text -----

These hedge assets are classified as a level 2 fair value measurement, being derived from inputs rather than quoted prices that are observable for the asset either directly (ie as prices) or indirectly (ie derived from prices).

Interest rate risk management

The consolidated entity is exposed to interest rate risk on the cash held in bank deposits. Cash in bank and term deposits of $13,840,000 were held by the consolidated entity at the reporting date, attracting an average interest rate of 4.2% (2011: 4.6%) If interest rates had been 50 basis points higher or lower and all other variables were held constant, the consolidated entity’s net profit would increase/(decrease) by $69,000 (2011: $67,000).

Note 20. Financial instruments (cont.)

Credit risk management

Credit risk refers to the risk that a counterparty will default on its contractual obligations resulting in financial loss to the consolidated entity. The consolidated entity has adopted a policy of only dealing with creditworthy counterparties and obtaining sufficient collateral where appropriate, as a means of mitigating the risk of financial loss from defaults.

Trade receivables consist of a large number of customers, spread across diverse industries and geographical areas. Ongoing credit evaluation is performed on the financial condition of accounts.

The consolidated entity does not have any significant credit risk exposure to any single counterparty or any consolidated entity of counterparties having similar characteristics. The credit risk on liquid funds and derivative financial instruments is limited because the counterparties are banks with high credit ratings assigned by international credit-rating agencies.

Liquidity risk management

Ultimate responsibility for liquidity risk management rests with the board of directors, who have built an appropriate liquidity risk management framework for the management of the consolidated entity’s short, medium and long-term funding and liquidity management requirements.

The consolidated entity manages liquidity risk by maintaining adequate reserves, by continuously monitoring forecast and actual cash flows and matching the maturity profiles of financial assets and liabilities.

All creditor and other payables shown in Note 15 for both 2012 and 2011 carry no interest obligation and have a maturity of less than three months.

Fair value of financial instruments

The carrying value of financial assets and financial liabilities of the consolidated entity is a reasonable approximation of their fair value.

Note 21. Operating leases

Non-cancellable operating lease rentals is for office space with payables as follows:

==> picture [483 x 103] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD 2012 2011
Less than one year 1,140 1,004
Between one and five years 3,303 3,648
Greater than five years - 542
4,443 5,194
----- End of picture text -----

Note 22. Consolidated entities

==> picture [483 x 146] intentionally omitted <==

----- Start of picture text -----

Ownership interest
Country of 2012 2011
In thousands of AUD incorporation
Parent entity:
Integrated Research Limited Australia
Subsidiaries:
Integrated Research, Inc USA 100% 100%
Integrated Research UK Limited UK 100% 100%
----- End of picture text -----

66 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 67

Notes to the Financial Statements | page 43 – 73

Note 23. Reconciliation of cash flows from operating activities

==> picture [484 x 337] intentionally omitted <==

----- Start of picture text -----

Consolidated
In thousands of AUD 2012 2011
Profit for the year 9,035 7,465
Depreciation and amortisation 7,489 6,561
Provision for doubtful debts 272 (226)
Allowance for returns 303 (655)
Interest received (509) (381)
Share-based payments expense 127 (89)
Net exchange differences 117 181
Change in operating assets and liabilities:
(Increase)/decrease in trade debtors (6,880) 1,867
(Increase)/decrease in future income tax benefit (167) 456
(Increase)/decrease in other operating assets 580 (538)
Increase/(decrease) in trade and other payables 920 275
Increase/(decrease) in other operating liabilities 2,628 (1,703)
Increase/(decrease) in provision for income taxes payable (11) 1,453
Increase/(decrease) in provision for deferred income taxes 398 (868)
Increase/(decrease) in other provisions 344 56
Net cash from operating activities 14,646 13,854
----- End of picture text -----

Note 24. Key management personnel disclosures

The following were key management personnel of the consolidated entity at any time during the reporting period and unless otherwise indicated were key management personnel for the entire period:

Directors (full year)	Other key management personnel (full year)	Other key management personnel (part year)
Steve Killelea Chairman	Peter Adams Chief Financial Ofcer	Geof Bryant Vice President Consultng
		(resigned Nov 2011)
Mark Brayan	Alex Baburin	Andrew Levido
Chief Executve Ofcer	General Manager, Research and Development	General Manager, Global Sales
		(appointed May 2012)
Alan Baxter	Brian Bigley
	Vice President Europe
John Brown	Andre Cuenin
	President Americas
Kate Costello	John Dunne
	General Manager, Products and Alliances
Peter Lloyd	David Leighton
	Company Secretary(retred July 2012)
Clyde McConaghy	Pierre Semaan Vice President Asia Pacifc

Note 24. Key management personnel disclosures (cont.)

Key management personnel compensation

The key management personnel compensation are as follows:

==> picture [483 x 103] intentionally omitted <==

----- Start of picture text -----

Consolidated
In AUD 2012 2011
Short-term benefits 2,850,541 3,088,424
Post-employment benefits 176,890 162,692
Equity compensation benefits 52,402 (36,079)
3,079,833 3,215,037
----- End of picture text -----

Individual directors and executives compensation disclosures

Information regarding individual directors and executives compensation is provided in the remuneration report on pages 24 to 31.

Apart from the details disclosed in this note, no director has entered into a material contract with the consolidated entity since the end of the previous financial year and there were no material contracts involving directors’ interests existing at year-end.

Key management personnel transactions with the consolidated entity

It is the consolidated entity’s policy that service contracts for executive directors and senior executives be unlimited in term but capable of termination by either party on one months notice and that the consolidated entity retains the right to terminate the contract immediately by payment in lieu of notice or a severance payment or an amount for redundancy equal to the scale of payments prescribed in the NSW Employment Protection Act.

Information regarding individual key management personnel’s service contracts is provided in the remuneration report on pages 26 to 27.

Equity instruments

All options refer to options over ordinary shares of Integrated Research Limited, which are exercisable on a one-forone basis under the Employee Share Option Plan (ESOP).

All performance rights refer to performance rights over ordinary shares of Integrated Research Limited, which are exercisable on a one-for-one basis under the Integrated Research Performance Rights and Option Plan (IRPROP).

68 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 69

Notes to the Financial Statements | page 43 – 73

Note 24. Key management personnel disclosures (cont.)

Options over equity instruments granted as compensation

The movement during the reporting year in the number of options over ordinary shares in Integrated Research Limited held directly, indirectly or beneficially, by each key management person, including their related parties, is as follows:

Current Year	Held at	Granted as	Exercised	Other	Held at	Vested	Vested and
	1 July	compensaton		changes*	30 June	during	exercisable at
	2011				2012	the year	30 June 2012
Directors
Mark Brayan	1,000,000	-	-	-	1,000,000	250,000	500,000
Executves
Peter Adams	350,000	-	-	-	350,000	87,500	87,500
Alex Baburin	200,000	-	-	(160,000)	40,000	10,000	10,000
Andre Cuenin	300,000	-	-	-	300,000	75,000	75,000
Pierre Semaan	200,000	-	-	-	200,000	50,000	50,000
John Dunne	50,000	-	(35,000)		15,000	7,500	7,500


Prior Year	Held at	Granted as	Exercised	Other	Held at	Vested	Vested and
	1 July	compensaton		changes*	30 June	during	exercisable at
	2010				2011	the year	30 June 2011
Directors
Mark Brayan	1,000,000	-	-	-	1,000,000	-	250,000
Executves
Peter Adams	350,000	-	-	-	350,000	-	-
Alex Baburin	200,000	-	-	-	200,000	-	-
Andre Cuenin	300,000	-	-	-	300,000	-	-
Rick Ferguson	300,000	-	-	(300,000)	-	-	-
Pierre Semaan	200,000	-	-	-	200,000	-	-
John Dunne	50,000	-	-	-	50,000	-	35,000

Note 24. Key management personnel disclosures (cont.)

Performance rights over equity instruments granted as compensation

The movement during the reporting year in the number of performance rights over ordinary shares in Integrated Research Limited held directly, indirectly or beneficially, by each key management person, including their related parties, is as follows:

==> picture [483 x 211] intentionally omitted <==

----- Start of picture text -----

Current Year Held at Granted as Exercised Other Held at Vested Vested and
1 July compensation changes * 30 June during exercisable at
2011 2012 the year 30 June 2012
Directors
- - - - -
Mark Brayan 170,000 170,000
Executives
Peter Adams - 100,000 - - 100,000 - -
Alex Baburin - 75,000 - - 75,000 - -
- - - - -
Brian Bigley 65,000 65,000
Andre Cuenin - 75,000 - - 75,000 - -
Pierre Semaan - 65,000 - - 65,000 - -
John Dunne - 75,000 - - 75,000 - -
----- End of picture text -----

Other changes represent performance rights that expired or were forfeited during the year

The performance rights offered to executives are subject to the consolidated entity achieving profit after tax performance hurdles. The next available testing date is August 2014. Performance rights expire on the earlier of their expiry date or termination of the individual’s employment. No performance rights have been granted since the end of the financial year. The performance rights were provided at no cost to the recipients.

There were no performance rights granted in the 2011 financial year.

Other changes represent options that expired or were forfeited during the year

There were no options granted as compensation during the current year.

25% of options granted vest annually on the anniversary of the grant date, and may also be subject to the consolidated entity achieving certain performance hurdles. Options expire on the earlier of their expiry date or termination of the individual’s employment. No options have been granted since the end of the financial year. The options were provided at no cost to the recipients.

70 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 71

Notes to the Financial Statements | page 43 – 73

Note 24. Key management personnel disclosures (cont.)

Movements in shares

The movement during the reporting period in the number of ordinary shares in Integrated Research Limited held directly, indirectly or beneficially, by each key management person, including their related parties, is as follows:

==> picture [488 x 380] intentionally omitted <==

----- Start of picture text -----

Current Year Held at Purchases Received on Received as Sales Vested and
1 July 2011 exercise compensation exercisable at
of options 30 June 2012
Directors: Non-executive
Alan Baxter 100,000 - - - - 100,000
John Brown 101,000 - - - - 101,000
Kate Costello 200,000 - - - - 200,000
Steve Killelea 94,834,951 - - - - 94,834,951
Directors: Executive
- - - -
Mark Brayan 25,000 25,000
Prior Year Held at Purchases Received on Received as Sales Vested and
1 July 2010 exercise compensation exercisable at
of options 30 June 2011
Directors: Non-executive
Alan Baxter - 100,000 - - - 100,000
John Brown 101,000 - - - - 101,000
Kate Costello 200,000 - - - - 200,000
Steve Killelea 94,834,951 - - - - 94,834,951
Directors: Executive
- - - -
Mark Brayan 25,000 25,000
----- End of picture text -----

Shareholdings at the date of the Directors’ Report for existing Key Management Personnel remain unchanged.

Other transactions with the consolidated entity

There were no other transactions between the key management personnel, or their personally-related entities, and the consolidated entity.

Note 25. Related parties

The consolidated entity has a related party relationship with its key management personnel (see note 24).

At 30 June 2012 Mr Steve Killelea, the Chairman of the Company, owned either directly or indirectly 56.41% of the Company (2011: 56.84%).

Note 26. Parent entity disclosures

Financial Position

==> picture [483 x 319] intentionally omitted <==

----- Start of picture text -----

Parent Entity
In thousands of AUD 2012 2011
Assets
Current assets 19,055 20,810
Non-current assets 17,479 17,926
Total assets 36,534 38,736
Liabilities
Current liabilities 6,672 10,488
Non-current liabilities 3,861 3,434
Total liabilities 10,533 13,922
Net assets 26,001 24,814
Equity
Issued capital 1,175 845
Employee benefits reserve 276 266
Hedging reserve - 147
Retained earnings 24,550 23,556
Total equity 26,001 24,814
----- End of picture text -----

Financial Performance

==> picture [483 x 88] intentionally omitted <==

----- Start of picture text -----

Parent Entity
In thousands of AUD 2012 2011
Profit for the year 8,470 6,864
Other comprehensive income (147) 245
Total comprehensive income 8,323 7,109
----- End of picture text -----

Note 27. Subsequent events

For dividends declared after 30 June 2012 see Note 19 in the financial statements. The financial effect of dividends declared and paid after 30 June 2012 have not been brought to account in the financial statements for the year ended 30 June 2012 and will be recognised in subsequent financial reports.

No other transaction or event of a material or unusual nature has arisen in the interval between the end of the financial year and the date of this report, which is likely, in the opinion of the directors of the company, to affect significantly the operations of the consolidated entity, the results of those operations, or the state of affairs of the consolidated entity, in future financial years.

72 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 73

Independent Audit Report | page 75 – 77

74 Directors’ Declaration

The directors declare that:

(a) in the directors’ opinion, there are reasonable grounds to believe that the company will be able to pay its debts as and when they become due and payable;
(b) the financial statements are in compliance with International Financial Reporting Standards, as stated in Note 1 to
the financial statements;
(c) in the directors’ opinion, the financial statements and notes thereto are in accordance with the Corporations Act 2001, including compliance with accounting standards and giving a true and fair view of the financial position and performance of the consolidated entity; and
(d) the directors have been given the declarations required by Section 295A of the Corporations Act 2001.

Deloitte Touche Tohmatsu ABN 74 490 121 060 Grosvenor Place 225 George Street Sydney NSW 2000 PO Box N250 Grosvenor Place Sydney NSW 1219 Australia DX 10307SSE Tel: +61 (0) 2 9322 7000 Fax: +61 (0) 2 9322 7001 www.deloitte.com.au

Independent Auditor’s Report to the members of Integrated Research Limited

Report on the Financial Report

We have audited the accompanying financial report of Integrated Research Limited, which comprises the statement of financial position as at 30 June 2012, the statement of comprehensive income, the statement of cash flows and the statement of changes in equity for the year ended on that date, notes comprising a summary of significant accounting policies and other explanatory information, and the directors’ declaration of the consolidated entity, comprising the company and the entities it controlled at the year’s end or from time to time during the financial year as set out on pages 39 to 74.

Directors’ Responsibility for the Financial Report

Signed in accordance with a resolution of the directors made pursuant to Section 295(5) of the Corporations Act 2001.

Dated at North Sydney this 21st day of August 2012.

The directors of the company are responsible for the preparation of the financial report that gives a true and fair view in accordance with Australian Accounting Standards and the Corporations Act 2001 and for such internal control as the directors determine is necessary to enable the preparation of the financial report that gives a true and fair view and is free from material misstatement, whether due to fraud or error. In Note 1, the directors also state, in accordance with Accounting Standard AASB 101 Presentation of Financial Statements , that the consolidated financial statements comply with International Financial Reporting Standards.

Auditor’s Responsibility

==> picture [135 x 63] intentionally omitted <==

Steve Killelea Chairman

==> picture [172 x 65] intentionally omitted <==

Mark Brayan Chief Executive Officer

Our responsibility is to express an opinion on the financial report based on our audit. We conducted our audit in accordance with Australian Auditing Standards. Those standards require that we comply with relevant ethical requirements relating to audit engagements and plan and perform the audit to obtain reasonable assurance whether the financial report is free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial report. The procedures selected depend on the auditor’s judgement, including the assessment of the risks of material misstatement of the financial report, whether due to fraud or error. In making those risk assessments, the auditor considers internal control, relevant to the company’s preparation of the financial report that gives a true and fair view, in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of accounting estimates made by the directors, as well as evaluating the overall presentation of the financial report.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Liability limited by a scheme approved under Professional Standards Legislation. Member of Deloitte Touche Tohmatsu Limited

74 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 75

Independent Audit Report | page 75 – 77

Deloitte Touche Tohmatsu ABN 74 490 121 060 Grosvenor Place 225 George Street Sydney NSW 2000 PO Box N250 Grosvenor Place Sydney NSW 1219 Australia DX 10307SSE

Tel: +61 (0) 2 9322 7000 Fax: +61 (0) 2 9322 7001 www.deloitte.com.au

Auditor’s Independence Declaration

In conducting our audit, we have complied with the independence requirements of the Corporations Act 2001 . We confirm that the independence declaration required by the Corporations Act 2001 , which has been given to the directors of Integrated Research Limited, would be in the same terms if given to the directors as at the time of this auditor’s report.

Opinion

In our opinion:

The Board of Directors

Integrated Research Limited Level 9, 100 Pacific Highway, NORTH SYDNEY, NSW, 2000

21 August 2012

(a) the financial report of Integrated Research Limited is in accordance with the Corporations Act 2001 , including:
(i) giving a true and fair view of the consolidated entity’s financial position as at 30 June 2012 and of its performance for the year ended on that date; and
(ii) complying with Australian Accounting Standards and the Corporations Regulations 2001 ; and
(b) the consolidated financial statements also comply with International Financial Reporting Standards as disclosed in Note 1.

Report on the Remuneration Report

We have audited the Remuneration Report included in pages 24 to 31 of the directors’ report for the year ended 30 June 2012. The directors of the company are responsible for the preparation and presentation of the Remuneration Report in accordance with section 300A of the Corporations Act 2001. Our responsibility is to express an opinion on the Remuneration Report, based on our audit conducted in accordance with Australian Auditing Standards.

Opinion

Dear Board Members

Auditor’s Independence Declaration to Integrated Research Limited

In accordance with section 307C of the Corporations Act 2001, I am pleased to provide the following declaration of independence to the directors of Integrated Research Limited.

As lead audit partner for the audit of the financial statements of Integrated Research Limited for the financial year ended 30 June 2012, I declare that to the best of my knowledge and belief, there have been no contraventions of:

(i) the auditor independence requirements of the Corporations Act 2001 in relation to the audit; and
(ii) any applicable code of professional conduct in relation to the audit.

Yours sincerely

In our opinion the Remuneration Report of Integrated Research Limited for the year ended 30 June 2012, complies with section 300A of the Corporations Act 2001.

DELOITTE TOUCHE TOHMATSU

==> picture [80 x 52] intentionally omitted <==

Weng W Ching Partner Chartered Accountants Sydney, 21 August 2012

==> picture [81 x 52] intentionally omitted <==

Weng W Ching Partner Chartered Accountants Sydney, 21 August 2012

Liability limited by a scheme approved under Professional Standards Legislation. Member of Deloitte Touche Tohmatsu Limited

76 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 77

ASX Additional Information | page 78 – 80

78 ASX Additional Information

Shareholder information

Analysis of numbers of equity security holders by size of holding as at 3 September 2012

	Class of equity security
	Ordinary shares
	Shares Optons Performance Rights
1 -1,000	162 - -
1,001 - 5,000	1,082 17 37
5,001 - 10,000	676 17 51
10,001 - 100,000	1,039 20 34
100,001 and over	88 3 1
	3,047 57 123

Equity security holders

Twenty largest quoted equity security holders

The names of the twenty largest holders of quoted equity securities as at 3 September 2012 are listed below:

==> picture [483 x 383] intentionally omitted <==

----- Start of picture text -----

Ordinary Shares
Number held Percentage of issued shares
1 Mr Stephen John Killelea 94,497,339 56.19
2 Mr Andrew Rhys Rutherford 4,485,869 2.67
3 B & R James Investments Pty Limited 3,000,000 1.78
4 Citicorp Nominees Pty Limited 1,476,193 0.88
5 Custodial Services Limited 1,305,650 0.78
6 Spectrok Pty Ltd 1,270,472 0.76
7 J P Morgan Nominees Australia Limited 1,241,545 0.74
8 Aust Executor Trustees SA Ltd 875,597 0.52
9 258 Investments Pty Ltd 850,000 0.51
10 Forsyth Barr Custodians Ltd 809,970 0.48
11 Mr Kevin John Cairns + Mrs Catherine Valerie Cairns 766,752 0.46
12 ABN Amro Clearing Sydney Nominees Pty Ltd 649,414 0.39
13 Spectrok Pty Ltd 641,359 0.38
14 Garrett Smythe Ltd 563,155 0.33
15 Bell Potter Nominees Ltd 532,000 0.32
16 Oates Super Pty Ltd 420,000 0.25
17 Mr Rodney Walter Ross 417,050 0.25
18 Howard Securities Pty Ltd 400,000 0.24
19 Fergfam Nominees Pty Ltd 375,263 0.22
20 Mr Mark Ronald Gerard Brayan 375,000 0.22
----- End of picture text -----

78 | Integrated Research and its controlled entities | Annual Report 2012

Annual Report 2012 | Integrated Research and its controlled entities | 79

Unquoted equity securities

==> picture [484 x 86] intentionally omitted <==

----- Start of picture text -----

||||
|---|---|---|
|Number on issue|Number of holders|
|Options issued under the Integrated Research Limited|
|Employee Option Plan to take up ordinary shares|1,472,500|57|
|Performance rights issued under the Integrated Research|
|Limited Performance Rights and Options Plan to take up|
|ordinary shares|1,534,500*|123|

----- End of picture text -----

Number of unissued ordinary shares under the options.
** Number of unissued ordinary shares under the performance rights.

On-market buy-back

There is no current on-market buy-back.

Substantial holders

Substantial holders in the Company are set out below:

==> picture [484 x 33] intentionally omitted <==

----- Start of picture text -----

||||
|---|---|---|
|Number held|Percentage|
|Stephen John Killelea*|94,834,951|56.33|

----- End of picture text -----

Includes direct and indirect holdings.

Voting rights

The voting rights attaching to each class of equity securities are set out below:

1. Ordinary shares.

On a show of hands every member present at a meeting in person or by proxy shall have one vote and upon a poll each share shall have one vote.

2. Options.

No voting rights.

3. Performance rights. No voting rights.

Other information

Integrated Research Limited, incorporated and domiciled in Australia, is a publicly listed company limited by shares.

Corporate Directory

==> picture [495 x 631] intentionally omitted <==

----- Start of picture text -----

|||
|---|---|
|Directors|Steve Killelea|
|Chairman and Non-Executive Director|
|Mark Brayan|
|Managing Director and CEO|
|Alan Baxter|
|Independent Non-Executive Director|
|John Brown|
|Independent Non-Executive Director|
|Kate Costello|
|Independent Non-Executive Director|
|Peter Lloyd|
|Independent Non-Executive Director|
|Clyde McConaghy|
|Non-Executive Director|
|Secretary|David Purdue|
|Registered Office|Level 9, 100 Pacific Highway|
|North Sydney, NSW, 2060|
|Phone: (+61 2) 9966 1066|
|Share Registry|Computershare|
|Auditors|Deloitte Touche Tohmatsu|
|225 George Street|
|Sydney, NSW, 2000|
|Solicitors|Ashurst|
|Level 36, Grosvenor Place|
|225 George Street|
|Sydney, NSW, 2000|
|Bankers|Westpac Banking Corporation|
|Securities Exchange Listing|Australian Securities Exchange|
|Code IRI|
|Country of Incorporation|Integrated Research Limited, incorporated and domiciled in Australia, is a|
|publicly listed company limited by shares.|
|Notice of Annual General Meeting|The Annual General Meeting of Integrated Research Limited will be held at|
|3:00pm on Thursday, 15 November 2012, at the Museum of Sydney, Corner of|
|Phillip and Bridge Streets, Sydney.|

----- End of picture text -----

80 | Integrated Research and its controlled entities | Annual Report 2012

Corporate HQ Asia Pacific/Middle East/Africa

Integrated Research Ltd Level 9/100 Pacific Highway North Sydney NSW 2060 Australia +61 (2) 9966 1066 +61 (2) 9966 1042 [email protected]

Americas – West Coast

Integrated Research Inc. 8055 East Tufts Avenue Suite 950 Denver CO 80237 +1 (303) 390 8700 +1 (303) 390 8777 info.usa @ir.com

Americas – East Coast

Integrated Research Inc. 1818 Library Street Suite 500 Reston VA 20190 +1 (703) 956 3016 +1 (303) 390 8777 [email protected]

Europe

Integrated Research UK Ltd Orchard Lea, Drift Road Winkfield, Windsor Berkshire SL4 4RP +44 (0) 1344 894 200 +44 (0) 1344 890 851 [email protected]

www.ir.com For more information visit our website at or our community blog at www.realtime.ir.com

AI assistant

INTEGRATED RESEARCH LIMITED — Annual Report 2012

65142_rns_2012-10-09_e64613a8-7cd1-4317-83a9-449a6c6bdf55.pdf

Contents

2012 Highlights

In millions of local currency

Total revenue

Letter from the Chairman

4

Dear fellow shareholders,

Despite the strength in the

Steve Killelea

IR: innovating solutions for our customers in global markets

Who we are

Integrated Research

What we do

Capabilities

Why we succeed

Competitive Advantage

Why customers buy

Value Proposition

8 Chief Executive Officer’s Report

Dear Shareholders,

10 Review of Operations and Activities

Expenses

Principal activities

Group overview

Review and results of operations

Revenue

Shareholder returns

Financial position

Outlook and Strategy for 2013

Directors

Steve Killelea, AM

Non-Executive Director and Chairman

MBA Mark Brayan,

Managing Director and Chief Executive Officer

Alan Baxter, BSc, DipEd

Independent Non-Executive Director

John Brown, BCom, FCA, MAICD Independent Non-Executive Director

Kate Costello, LLB, FAICD Independent Non-Executive Director

Clyde McConaghy, BBus, MBA, MAICD, MIOD – UK Non-Executive Director

Peter Lloyd

Independent Non-Executive Director

David Purdue,

David Leighton,

BEc, MBA, GradDip CSP, FCA, FCIS, FCSA, GAICD Company Secretary

MBA, FCPA, ACIS

Company Secretary

Peter Adams, BCom, CA

Chief Financial Officer

Alex Baburin, BAppSc

General Manager, Research and Development

Brian Bigley

Vice President Europe

Andre Cuenin, BSc, MBA

President Americas

John Dunne, BInfTech, MBT

General Manager, Products & Alliances

Andrew Levido, BEng, MBA

General Manager, Global Sales

Melanie Newman, HRM PGDip

General Manager, Human Resources

Pierre Semaan, BEng, MBA Vice President Asia Pacific

18

Directors’ Report

Results

Dividends

Principal activities and review of operations

Events subsequent to reporting date

Directors and company secretary

Officers who were previously partners of the audit firm

Directors’ meetings

State of affairs

Environmental regulation

Future developments

Directors’ interests

Share options and performance rights

Options and performance rights granted to directors and senior executives

Unissued shares under option and performance rights

INTEGRATED RESEARCH LIMITED Annual Report 2012